RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Respiratory Tract Infections |
|
Accession: | DOID:9008680
|
browse the term
|
Definition: | Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. |
Synonyms: | exact_synonym: | Respiratory Infection, Upper; Respiratory Infections; Respiratory Tract Infection; Upper Respiratory Infections; Upper Respiratory Tract Infections |
| primary_id: | MESH:D012141; RDO:0000329 |
|
|
|
G |
BDNF |
brain derived neurotrophic factor |
|
IEP |
protein:decreased expression:platelet, serum |
RGD |
PMID:17317133 |
RGD:4891069 |
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:19039768 |
RGD:4892119 |
NCBI chr X:71,615,919...71,618,511
Ensembl chr X:71,615,916...71,618,511
|
|
G |
FBLN5 |
fibulin 5 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12189163 |
|
NCBI chr14:91,869,411...91,947,694
Ensembl chr14:91,869,411...91,947,987
|
|
G |
HLA-G |
major histocompatibility complex, class I, G |
|
IAGP |
|
RGD |
PMID:19775370 |
RGD:5144114 |
NCBI chr 6:29,826,474...29,831,021
Ensembl chr 6:29,826,967...29,831,125
|
|
G |
IL13 |
interleukin 13 |
|
IEP |
Severe Acute Respiratory Syndrome |
RGD |
PMID:14633438 |
RGD:4145665 |
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
|
|
G |
IL16 |
interleukin 16 |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:14633438 |
RGD:4145665 |
NCBI chr15:81,182,712...81,314,058
Ensembl chr15:81,159,575...81,314,058
|
|
G |
IL4 |
interleukin 4 |
|
IEP |
associated with Asthma |
RGD |
PMID:20573437 |
RGD:5128554 |
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL6R |
interleukin 6 receptor |
|
IAGP |
DNA:polymorphisms:promoter, exon:-183G>A (human) |
RGD |
PMID:20951753 |
RGD:5128631 |
NCBI chr 1:154,405,343...154,469,450
Ensembl chr 1:154,405,193...154,469,450
|
|
G |
IRF1 |
interferon regulatory factor 1 |
|
ISO |
|
RGD |
PMID:10497103 |
RGD:5128721 |
NCBI chr 5:132,481,609...132,490,773
Ensembl chr 5:132,440,440...132,508,719
|
|
G |
IRF3 |
interferon regulatory factor 3 |
|
ISO |
|
RGD |
PMID:17027894 |
RGD:5128795 |
NCBI chr19:49,659,572...49,665,857
Ensembl chr19:49,659,569...49,665,875
|
|
G |
LEPR |
leptin receptor |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17229951 |
|
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
IEP IAGP |
protein:decreased secretion:serum (human) DNA:polymorphisms:5' utr, exon:multiple (human) DNA:SNP:exon:p.G54D(rs1800450)(human) |
RGD |
PMID:19169708 PMID:19767106 PMID:15249448 |
RGD:4889453, RGD:4889439, RGD:8693755 |
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
|
|
G |
MX1 |
MX dynamin like GTPase 1 |
|
IEP |
protein:increased expression:blood (human) |
RGD |
PMID:25542463 |
RGD:126777677 |
NCBI chr21:41,420,558...41,459,214
Ensembl chr21:41,420,020...41,470,071
|
|
G |
RPGR |
retinitis pigmentosa GTPase regulator |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12920075 |
|
NCBI chr X:38,269,163...38,327,509
Ensembl chr X:38,269,163...38,327,544
|
|
G |
TNF |
tumor necrosis factor |
|
IEP |
Severe Acute Respiratory Syndrome; protein:increased expression:serum |
RGD |
PMID:14633438 |
RGD:4145665 |
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
|
G |
CCL17 |
C-C motif chemokine ligand 17 |
|
IEP |
associated with Cystic Fibrosis |
RGD |
PMID:17898016 |
RGD:4145612 |
NCBI chr16:57,396,093...57,416,063
Ensembl chr16:57,404,767...57,416,063
|
|
G |
CCR1 |
C-C motif chemokine receptor 1 |
|
ISO |
|
RGD |
PMID:15951834 |
RGD:5688155 |
NCBI chr 3:46,201,711...46,208,313
Ensembl chr 3:46,201,711...46,208,313
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:10946288 |
RGD:8661731 |
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
|
|
G |
CFTR |
CF transmembrane conductance regulator |
|
IAGP |
DNA:mutations: : |
RGD |
PMID:11243954 |
RGD:4140482 |
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
|
|
G |
HLA-DQB1 |
major histocompatibility complex, class II, DQ beta 1 |
susceptibility |
IAGP |
associated with cystic fibrosis; DNA:polymorphisms: :DQB1*06:02, DQB1*02:01(human) |
RGD |
PMID:23278646 |
RGD:36049760 |
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
|
|
G |
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1 |
susceptibility |
IAGP |
associated with cystic fibrosis; DNA:polymorphisms: : |
RGD |
PMID:23278646 |
RGD:36049760 |
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:7743671 |
RGD:8547590 |
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
|
RGD |
PMID:8699818 |
RGD:7794730 |
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
IAGP |
Chronic Necrotizing Pulmonary Aspergillosis; DNA:missense mutation:exon:p.R52C (human) DNA:SNP:intron:1011G>A(human) |
RGD |
PMID:11474427 PMID:16487239 |
RGD:4889577, RGD:8693711 |
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
|
|
G |
TLR9 |
toll like receptor 9 |
susceptibility |
ISO IAGP |
DNA:SNP:promoter:g.-1237T>C (rs5743836) (human) |
RGD |
PMID:18936185 PMID:18275280 |
RGD:5130858, RGD:5130863 |
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
|
RGD |
PMID:8699818 |
RGD:7794730 |
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
susceptibility |
IAGP |
DNA:snps:5' utr, exon:g.-609G>T rs4149570, g.36A>G rs767455 (human) |
RGD |
PMID:20646338 |
RGD:5131174 |
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
severity |
IAGP |
DNA:snp:exon:c.1236C>T (human) |
RGD |
PMID:24040855 |
RGD:8657076 |
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ACE |
angiotensin I converting enzyme |
no_association |
IAGP |
DNA:deletion:intron:IVS16+1464-1751del (human) |
RGD |
PMID:15112973 |
RGD:8142345 |
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
|
ISO |
mRNA, protein:increased expression:nasal mucosa (rat) |
RGD |
PMID:15362690 |
RGD:11522724 |
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
CAT |
catalase |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29028686 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL11 |
C-C motif chemokine ligand 11 |
treatment |
ISO |
|
RGD |
PMID:23089405 |
RGD:7248414 |
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
|
|
G |
CCL26 |
C-C motif chemokine ligand 26 |
|
IEP |
protein:increased expression:oronasal secretion (human) |
RGD |
PMID:23883806 |
RGD:7364793 |
NCBI chr 7:75,769,524...75,791,597
Ensembl chr 7:75,769,533...75,789,896
|
|
G |
CD40 |
CD40 molecule |
|
IEP |
protein:increased expression:lymphocyte |
RGD |
PMID:19086656 |
RGD:8547782 |
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
|
|
G |
CD40LG |
CD40 ligand |
|
IEP |
protein:increased expression:lymphocyte |
RGD |
PMID:19086656 |
RGD:8547782 |
NCBI chr X:136,648,158...136,660,390
Ensembl chr X:136,648,158...136,660,390
|
|
G |
CLDN3 |
claudin 3 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33441633 |
|
NCBI chr 7:73,768,997...73,770,270
Ensembl chr 7:73,768,997...73,770,270
|
|
G |
CLDN7 |
claudin 7 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33441633 |
|
NCBI chr17:7,259,903...7,263,213
Ensembl chr17:7,259,903...7,263,983
|
|
G |
CTLA4 |
cytotoxic T-lymphocyte associated protein 4 |
treatment |
ISO |
|
RGD |
PMID:10436391 |
RGD:11344920 |
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
|
|
G |
F2 |
coagulation factor II, thrombin |
|
IEP |
protein:increased expression:nasal mucus |
RGD |
PMID:21711961 |
RGD:5147783 |
NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
|
|
G |
FCGR3A |
Fc gamma receptor IIIa |
susceptibility |
IAGP |
DNA:polymorphism:exon:p.F158V(rs396991)(human) |
RGD |
PMID:18199088 |
RGD:5508449 |
NCBI chr 1:161,541,759...161,550,737
Ensembl chr 1:161,541,759...161,550,968
|
|
G |
GRIA1 |
glutamate ionotropic receptor AMPA type subunit 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34624383 |
|
NCBI chr 5:153,489,615...153,813,869
Ensembl chr 5:153,489,615...153,813,869
|
|
G |
GRIA2 |
glutamate ionotropic receptor AMPA type subunit 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34624383 |
|
NCBI chr 4:157,220,120...157,366,075
Ensembl chr 4:157,204,182...157,387,146
|
|
G |
HLA-G |
major histocompatibility complex, class I, G |
|
IEP |
|
RGD |
PMID:20487636 |
RGD:5144132 |
NCBI chr 6:29,826,474...29,831,021
Ensembl chr 6:29,826,967...29,831,125
|
|
G |
HMOX1 |
heme oxygenase 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36127783 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HRH1 |
histamine receptor H1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23333628 |
|
NCBI chr 3:11,137,238...11,263,557
Ensembl chr 3:11,137,093...11,263,557
|
|
G |
IFNG |
interferon gamma |
treatment |
IEP EXP ISO |
associated with Asthma CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:29871060 PMID:12787306 PMID:18510219 |
RGD:7829803, RGD:10755770 |
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL10 |
interleukin 10 |
treatment |
IEP EXP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:36127783 PMID:23883806 PMID:23253209 |
RGD:7364793, RGD:7364818 |
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL13 |
interleukin 13 |
susceptibility no_association |
IAGP EXP |
DNA:SNP:promoter:-1512A>C (rs1881457) (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:exon:c. 2044G>A (human) DNA:missense mutation:cds:p.R130Q (rs20541) (human) DNA:SNPs:promoter, cds:-1112C>T, p.R130Q (rs1800925, rs20541) (human) |
CTD OMIM RGD |
PMID:23996716 PMID:17091279 PMID:22852128 PMID:12928861 |
RGD:8549501, RGD:4152796, RGD:8549518, RGD:8549516 |
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
|
|
G |
IL13RA2 |
interleukin 13 receptor subunit alpha 2 |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:21462799 |
RGD:8549521 |
NCBI chr X:115,003,982...115,017,616
Ensembl chr X:115,003,975...115,019,977
|
|
G |
IL17A |
interleukin 17A |
susceptibility |
IAGP IEP |
DNA:snp:promoter:c.-444A>G (human) mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:22507625 PMID:21535180 |
RGD:9068429, RGD:5147409 |
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL18 |
interleukin 18 |
severity no_association |
IAGP |
DNA:SNP:promoter:-137G>C (rs187238) (human) DNA:SNP:promoter:-140C>G (rs360721) (human) |
RGD |
PMID:22840759 PMID:22840759 |
RGD:8655914, RGD:8655914 |
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096
|
|
G |
IL1B |
interleukin 1 beta |
|
IEP |
protein:increased expression:nasal mucus |
RGD |
PMID:7750009 |
RGD:7401199 |
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL2 |
interleukin 2 |
|
ISO |
|
RGD |
PMID:12592663 |
RGD:8662963 |
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
|
|
G |
IL4 |
interleukin 4 |
treatment |
IEP EXP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:36127783 PMID:9893928 PMID:24620662 PMID:8908280 PMID:14653048 |
RGD:7829796, RGD:11522769, RGD:7829827, RGD:7829802 |
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL5 |
interleukin 5 |
treatment |
ISO |
|
RGD |
PMID:23934070 PMID:24620662 |
RGD:11354976, RGD:11522769 |
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
|
|
G |
ITGB2 |
integrin subunit beta 2 |
treatment |
ISO |
|
RGD |
PMID:12046991 |
RGD:9698435 |
NCBI chr21:44,885,953...44,928,815
Ensembl chr21:44,885,953...44,931,989
|
|
G |
MRC1 |
mannose receptor C-type 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36127783 |
|
NCBI chr10:17,809,348...17,911,164
Ensembl chr10:17,809,348...17,911,164
|
|
G |
MUC1 |
mucin 1, cell surface associated |
severity |
IEP ISO |
mRNA,protein:decreased expression:nasal mucosa |
RGD |
PMID:31425778 PMID:31425778 PMID:31425778 |
RGD:127345100, RGD:127345100, RGD:127345100 |
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
|
|
G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
|
ISO |
mRNA, protein:increased expression:nasal cavity epithelium |
RGD |
PMID:22972875 |
RGD:7364746 |
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
|
IEP |
mRNA:increased expression:nasal mucosa (human) |
RGD |
PMID:23858718 |
RGD:8547523 |
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
|
|
G |
OCLN |
occludin |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33441633 |
|
NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104
|
|
G |
PON1 |
paraoxonase 1 |
severity |
IEP |
protein:decreased activity:plasma (human) |
RGD |
PMID:23406590 |
RGD:8547583 |
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
|
|
G |
PRKG1 |
protein kinase cGMP-dependent 1 |
|
ISO |
protein:increased expression:nasal cavity epithelium |
RGD |
PMID:24012634 |
RGD:7775060 |
NCBI chr10:50,990,888...52,298,350
Ensembl chr10:50,990,888...52,298,423
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16979129 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
SCGB1A1 |
secretoglobin family 1A member 1 |
|
ISO |
mRNA:decreased expression:nasal mucosa, lung |
RGD |
PMID:17882576 |
RGD:5144135 |
NCBI chr11:62,419,033...62,423,195
Ensembl chr11:62,405,103...62,423,195
|
|
G |
SCGB3A2 |
secretoglobin family 3A member 2 |
susceptibility |
IAGP |
DNA:SNP: :rs7726552 (human) |
RGD |
PMID:21410962 |
RGD:5144225 |
NCBI chr 5:147,878,711...147,882,191
Ensembl chr 5:147,870,682...147,882,191
|
|
G |
SERPINE1 |
serpin family E member 1 |
|
ISO |
mRNA:increased expression:nasal mucosa (mouse) |
RGD |
PMID:21339035 |
RGD:8547809 |
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
|
|
G |
TACR1 |
tachykinin receptor 1 |
|
ISO |
mRNA:increased expression:nasal mucosa |
RGD |
PMID:12768696 |
RGD:5147835 |
NCBI chr 2:75,046,463...75,199,520
Ensembl chr 2:75,046,463...75,199,520
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
treatment |
ISO |
|
RGD |
PMID:31368266 |
RGD:14995445 |
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TLR2 |
toll like receptor 2 |
severity |
IAGP IEP ISO |
DNA:polymorphism:cds:p.R753Q(human) protein:increased expression:neutrophil: mRNA:decreased expression:nasal mucosa: |
RGD |
PMID:22402138 PMID:22555057 PMID:18381801 PMID:18219831 |
RGD:7800732, RGD:8552993, RGD:8552972, RGD:7800742 |
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
|
|
G |
TLR4 |
toll like receptor 4 |
severity treatment susceptibility no_association |
IAGP IEP IDA |
DNA:polymorphism:cds:p.D299G(human) protein:increased expression:nasal lavage,leukocyte, bone marrow: protein:decreased expression:nasal mucosa: DNA:SNP: :rs1927911(human) DNA:polymorphism: :4216G>C(human) |
RGD |
PMID:22402138 PMID:22555057 PMID:22577387 PMID:17069098 PMID:23639307 PMID:19763595 More...
|
RGD:7800732, RGD:8552993, RGD:7800740, RGD:7800738, RGD:7800736, RGD:4145354 |
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TLR9 |
toll like receptor 9 |
|
IEP |
protein:decreased expression:nasal mucosa: |
RGD |
PMID:22577387 |
RGD:7800740 |
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
|
|
|
G |
CYP2C19 |
cytochrome P450 family 2 subfamily C member 19 |
treatment |
IAGP |
associated with Eosinophilic Esophagitis; DNA:polymorphisms:: |
RGD |
PMID:26416193 |
RGD:11352743 |
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
|
|
G |
IL3 |
interleukin 3 |
susceptibility |
IAGP |
DNA:SNP: :rs40401(human) |
RGD |
PMID:23953855 |
RGD:13506915 |
NCBI chr 5:132,060,655...132,063,204
Ensembl chr 5:132,060,655...132,063,204
|
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
|
IAGP |
DNA:SNP:promoter:-374T>A (human) |
RGD |
PMID:22114731 |
RGD:8695981 |
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
|
|
G |
CCL19 |
C-C motif chemokine ligand 19 |
|
ISO |
associated with Neutropenia;mRNA:increased expression:lung |
RGD |
PMID:19783686 |
RGD:5130908 |
NCBI chr 9:34,689,570...34,691,276
Ensembl chr 9:34,689,570...34,691,276
|
|
G |
CCR7 |
C-C motif chemokine receptor 7 |
|
ISO |
associated with Neutropenia |
RGD |
PMID:19783686 |
RGD:5130908 |
NCBI chr17:40,553,769...40,565,472
Ensembl chr17:40,551,081...40,565,472
|
|
G |
CD209 |
CD209 molecule |
|
IMP |
|
RGD |
PMID:21381282 |
RGD:5131183 |
NCBI chr19:7,739,993...7,747,534
Ensembl chr19:7,739,993...7,747,564
|
|
G |
CFTR |
CF transmembrane conductance regulator |
severity |
ISO |
|
RGD |
PMID:22135344 |
RGD:35673332 |
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
|
|
G |
CLEC1A |
C-type lectin domain family 1 member A |
susceptibility |
IAGP EXP |
ClinVar Annotator: match by term: Aspergillosis, susceptibility to CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:25741868 PMID:29489751 |
|
NCBI chr12:10,069,554...10,098,985
Ensembl chr12:10,069,554...10,111,627
|
|
G |
CLEC7A |
C-type lectin domain containing 7A |
|
IAGP EXP |
ClinVar Annotator: match by term: CLEC7A-related condition CTD Direct Evidence: marker/mechanism |
ClinVar OMIM CTD |
PMID:19864674 PMID:20807886 PMID:24033266 PMID:25741868 PMID:28492532 |
|
NCBI chr12:10,116,777...10,130,304
Ensembl chr12:10,116,777...10,130,258
|
|
G |
CRP |
C-reactive protein |
treatment |
IEP |
|
RGD |
PMID:20879853 |
RGD:9495929 |
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
|
|
G |
IL15 |
interleukin 15 |
|
IAGP |
DNA:polymorphism (human) |
RGD |
PMID:16893395 |
RGD:4981337 |
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
|
|
G |
MBL1P |
mannose binding lectin 1, pseudogene |
susceptibility |
ISO |
|
RGD |
PMID:20064561 |
RGD:8694071 |
NCBI chr10:79,920,178...79,923,119
Ensembl chr10:79,920,327...79,923,032 Ensembl chr10:79,920,327...79,923,032
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
ISO |
|
RGD |
PMID:20064561 |
RGD:8694071 |
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
|
|
G |
S100B |
S100 calcium binding protein B |
|
IAGP |
DNA:SNP: :427C>T (human) |
RGD |
PMID:22114731 |
RGD:8695981 |
NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208
|
|
G |
TLR1 |
toll like receptor 1 |
susceptibility |
IAGP |
DNA:SNPs: :p.R80T, p.N248S (human) |
RGD |
PMID:16461792 |
RGD:4889535 |
NCBI chr 4:38,787,569...38,805,644
Ensembl chr 4:38,787,555...38,856,817
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19781388 |
RGD:4145322 |
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
|
|
G |
TLR6 |
toll like receptor 6 |
susceptibility |
IAGP |
DNA:SNP: :p.S249P (human) |
RGD |
PMID:16461792 |
RGD:4889535 |
NCBI chr 4:38,822,897...38,868,390
Ensembl chr 4:38,822,897...38,856,817
|
|
|
G |
ACE |
angiotensin I converting enzyme |
|
IMP |
associated with Cerebrovascular Accident |
RGD |
PMID:14990394 |
RGD:4140926 |
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:19515386 |
RGD:4891456 |
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
|
ISO |
|
RGD |
PMID:19515386 |
RGD:4891456 |
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
EDN1 |
endothelin 1 |
|
ISO |
protein:increased secretion:plasma (rat) |
RGD |
PMID:19262391 |
RGD:4145069 |
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
protein:increased expression:Bronchoalveolar Lavage Fluid |
RGD |
PMID:18042282 |
RGD:4142854 |
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15607125 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
protein:increased expression:Bronchoalveolar Lavage Fluid |
RGD |
PMID:18042282 |
RGD:4142854 |
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
severity |
IEP |
protein:increased expression:nasal mucus (human) |
RGD |
PMID:24211414 |
RGD:40925940 |
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
MARCO |
macrophage receptor with collagenous structure |
disease_progression |
ISO |
association with Cryptococcal neoformans infection. |
RGD |
PMID:28298522 |
RGD:41412191 |
NCBI chr 2:118,942,194...118,994,660
Ensembl chr 2:118,942,194...118,994,660
|
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 (ABCC1 blood group) |
|
ISO |
|
RGD |
PMID:11238654 |
RGD:5128828 |
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
|
|
G |
ACE2 |
angiotensin converting enzyme 2 |
|
ISO |
associated with Pseudomonas Infections;mRNA, protein:altered expression, altered activity:lung (mouse) |
RGD |
PMID:31645418 |
RGD:40818279 |
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
severity |
ISO |
|
RGD |
PMID:21629785 |
RGD:6767559 |
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:16014897 |
RGD:5129508 |
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
|
|
G |
C3AR1 |
complement C3a receptor 1 |
|
ISO |
|
RGD |
PMID:16461429 |
RGD:5129690 |
NCBI chr12:8,056,844...8,066,359
Ensembl chr12:8,056,844...8,066,359
|
|
G |
C5 |
complement C5 |
|
ISO |
|
RGD |
PMID:17975174 |
RGD:5129707 |
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
|
|
G |
CAT |
catalase |
|
ISO |
|
RGD |
PMID:19842849 |
RGD:5130748 |
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL19 |
C-C motif chemokine ligand 19 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:20176793 |
RGD:5130918 |
NCBI chr 9:34,689,570...34,691,276
Ensembl chr 9:34,689,570...34,691,276
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
|
RGD |
PMID:20042590 |
RGD:4891443 |
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL4 |
C-C motif chemokine ligand 4 |
|
ISO |
|
RGD |
PMID:20483921 |
RGD:5130905 |
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:20042590 |
RGD:4891443 |
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
|
|
G |
CCR7 |
C-C motif chemokine receptor 7 |
|
ISO |
|
RGD |
PMID:20176793 |
RGD:5130918 |
NCBI chr17:40,553,769...40,565,472
Ensembl chr17:40,551,081...40,565,472
|
|
G |
CD14 |
CD14 molecule |
|
ISO |
|
RGD |
PMID:16210672 |
RGD:4144197 |
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:20102413 |
RGD:5132268 |
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
|
|
G |
CD80 |
CD80 molecule |
|
ISO |
|
RGD |
PMID:20949109 |
RGD:4892562 |
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
|
|
G |
CHUK |
component of inhibitor of nuclear factor kappa B kinase complex |
|
ISO |
|
RGD |
PMID:18643924 |
RGD:5133701 |
NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596
|
|
G |
CSF3 |
colony stimulating factor 3 |
disease_progression treatment |
IEP IDA |
associated with Peritonitis; |
RGD |
PMID:21373266 PMID:12352049 |
RGD:5133733, RGD:11039437 |
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
|
|
G |
CSF3R |
colony stimulating factor 3 receptor |
disease_progression |
ISO |
|
RGD |
PMID:17185469 |
RGD:5133739 |
NCBI chr 1:36,466,043...36,483,314
Ensembl chr 1:36,466,043...36,483,278
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:21723409 PMID:11052817 |
RGD:5135062, RGD:5135234 |
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
severity |
ISO |
|
RGD |
PMID:16299319 PMID:15618188 |
RGD:5135458, RGD:5135459 |
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
CXCL11 |
C-X-C motif chemokine ligand 11 |
|
ISO |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr 4:76,033,682...76,036,070
Ensembl chr 4:76,033,682...76,041,415
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
severity |
ISO |
|
RGD |
PMID:19239431 PMID:11052817 PMID:21723409 |
RGD:5135065, RGD:5135234, RGD:5135062 |
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CXCL3 |
C-X-C motif chemokine ligand 3 |
|
ISO |
|
RGD |
PMID:11052817 |
RGD:5135234 |
NCBI chr 4:74,036,589...74,038,689
Ensembl chr 4:74,036,589...74,038,807
|
|
G |
CXCL5 |
C-X-C motif chemokine ligand 5 |
|
ISO |
|
RGD |
PMID:19846873 |
RGD:4145490 |
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
|
|
G |
CXCL6 |
C-X-C motif chemokine ligand 6 |
|
ISO |
|
RGD |
PMID:19846873 |
RGD:4145490 |
NCBI chr 4:73,836,678...73,838,760
Ensembl chr 4:73,836,640...73,849,064
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr X:71,615,919...71,618,511
Ensembl chr X:71,615,916...71,618,511
|
|
G |
CYP2J2 |
cytochrome P450 family 2 subfamily J member 2 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:14766666 |
RGD:1625385 |
NCBI chr 1:59,893,308...59,969,212
Ensembl chr 1:59,893,308...59,926,773
|
|
G |
DEFB4A |
defensin beta 4A |
|
IEP |
protein:increased expression:plasma |
RGD |
PMID:10213993 |
RGD:4892266 |
NCBI chr 8:7,894,677...7,896,716
Ensembl chr 8:7,894,677...7,896,716 Ensembl chr 8:7,894,677...7,896,716
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
|
RGD |
PMID:21897338 |
RGD:6893486 |
NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
|
|
G |
FCGR2A |
Fc gamma receptor IIa |
|
ISO |
|
RGD |
PMID:17975174 |
RGD:5129707 |
NCBI chr 1:161,505,457...161,524,048
Ensembl chr 1:161,505,430...161,524,013
|
|
G |
FOXP3 |
forkhead box P3 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800
|
|
G |
GP1BA |
glycoprotein Ib platelet subunit alpha |
exacerbates |
ISO |
associated with Escherichia Coli Infections |
RGD |
PMID:27845343 |
RGD:42722624 |
NCBI chr17:4,932,277...4,935,023
Ensembl chr17:4,932,277...4,935,023
|
|
G |
GRK2 |
G protein-coupled receptor kinase 2 |
|
IEP |
mRNA:decreased expression:polymorphonuclear leukocyte |
RGD |
PMID:24465168 |
RGD:126848796 |
NCBI chr11:67,266,473...67,286,556
Ensembl chr11:67,266,473...67,286,556
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased expression:lung (mouse) |
RGD |
PMID:19846873 |
RGD:4145490 |
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IFNAR1 |
interferon alpha and beta receptor subunit 1 |
severity |
ISO |
|
RGD |
PMID:19487810 PMID:19487810 |
RGD:5490274, RGD:5490274 |
NCBI chr21:33,324,395...33,359,864
Ensembl chr21:33,324,387...33,359,864
|
|
G |
IFNG |
interferon gamma |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL10 |
interleukin 10 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
|
RGD |
PMID:17911627 |
RGD:5000754 |
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
|
|
G |
IL17A |
interleukin 17A |
severity |
ISO |
|
RGD |
PMID:18802100 PMID:25398094 |
RGD:4889153, RGD:38501102 |
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:17664259 |
RGD:4889913 |
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096
|
|
G |
IL1B |
interleukin 1 beta |
severity treatment |
ISO IDA |
associated with Agranulocytosis |
RGD |
PMID:18596024 PMID:25398094 PMID:7546648 |
RGD:4143205, RGD:38501102, RGD:10755357 |
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL1RL1 |
interleukin 1 receptor like 1 |
treatment |
ISO |
associated with Sepsis associated with Acinetobacter infectious disease |
RGD |
PMID:20959556 PMID:29508184 |
RGD:5144223, RGD:40818077 |
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
ISO |
|
RGD |
PMID:18322242 PMID:18596024 |
RGD:4143206, RGD:4143205 |
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
|
|
G |
IL22 |
interleukin 22 |
|
ISO |
|
RGD |
PMID:21178015 |
RGD:5147404 |
NCBI chr12:68,248,242...68,253,604
Ensembl chr12:68,248,242...68,253,604
|
|
G |
IL6 |
interleukin 6 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
IRAK3 |
interleukin 1 receptor associated kinase 3 |
|
ISO |
|
RGD |
PMID:28120642 PMID:20439918 |
RGD:34888234, RGD:36049799 |
NCBI chr12:66,189,214...66,254,622
Ensembl chr12:66,189,195...66,254,622
|
|
G |
IRF1 |
interferon regulatory factor 1 |
|
ISO |
|
RGD |
PMID:11854220 |
RGD:5128725 |
NCBI chr 5:132,481,609...132,490,773
Ensembl chr 5:132,440,440...132,508,719
|
|
G |
IRF3 |
interferon regulatory factor 3 |
|
ISO |
|
RGD |
PMID:20720199 |
RGD:4891951 |
NCBI chr19:49,659,572...49,665,857
Ensembl chr19:49,659,569...49,665,875
|
|
G |
ITGB3 |
integrin subunit beta 3 |
|
ISO |
protein:increased expression:lung, neutrophil |
RGD |
PMID:15114484 |
RGD:4993468 |
NCBI chr17:47,253,827...47,313,743
Ensembl chr17:47,253,827...47,313,743
|
|
G |
LEP |
leptin |
|
ISO |
|
RGD |
PMID:11937559 |
RGD:5128871 |
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
severity |
ISO |
associated with Escherichia Coli Infections |
RGD |
PMID:22514650 |
RGD:150340681 |
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MBL2 |
mannose binding lectin 2 |
|
IAGP |
Legionella Pneumonia; DNA:mutations:5' utr, exon:multiple (human) |
RGD |
PMID:18641104 |
RGD:4889477 |
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
|
|
G |
MC1R |
melanocortin 1 receptor |
|
ISO |
|
RGD |
PMID:18304533 |
RGD:5687324 |
NCBI chr16:89,918,862...89,920,972
Ensembl chr16:89,912,119...89,920,973
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO IEP |
protein:increased expression:bronchoalveolar lavage fluid |
RGD |
PMID:17202364 PMID:19535150 |
RGD:5130727, RGD:5129533 |
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MPO |
myeloperoxidase |
|
IEP |
protein:increased activity:bronchoalveolar lavage Fluid: |
RGD |
PMID:11269653 |
RGD:5130992 |
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
NOD1 |
nucleotide binding oligomerization domain containing 1 |
|
ISO |
|
RGD |
PMID:19360122 |
RGD:5131449 |
NCBI chr 7:30,424,527...30,478,784
Ensembl chr 7:30,424,527...30,478,784
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
|
RGD |
PMID:19360122 |
RGD:5131449 |
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
|
|
G |
PDPN |
podoplanin |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:7864138 |
RGD:2292375 |
NCBI chr 1:13,583,757...13,617,957
Ensembl chr 1:13,583,465...13,617,957
|
|
G |
PECAM1 |
platelet and endothelial cell adhesion molecule 1 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:12524254 |
RGD:724645 |
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
|
|
G |
PGF |
placental growth factor |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:16702604 |
RGD:6483601 |
NCBI chr14:74,941,830...74,955,764
Ensembl chr14:74,941,834...74,955,626
|
|
G |
PTEN |
phosphatase and tensin homolog |
ameliorates |
ISO |
myeloid knockout |
RGD |
PMID:21527775 |
RGD:127285594 |
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
|
|
G |
RIPK3 |
receptor interacting serine/threonine kinase 3 |
ameliorates |
ISO |
|
RGD |
PMID:28387756 |
RGD:127229944 |
NCBI chr14:24,336,025...24,339,991
Ensembl chr14:24,336,025...24,340,022
|
|
G |
RORC |
RAR related orphan receptor C |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 1:151,806,071...151,831,802
Ensembl chr 1:151,806,071...151,831,845
|
|
G |
SERPINE1 |
serpin family E member 1 |
severity |
ISO |
|
RGD |
PMID:17032919 |
RGD:4144840 |
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
|
|
G |
SFTPA1 |
surfactant protein A1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:12169586 |
RGD:4143464 |
NCBI chr10:79,610,939...79,615,455
Ensembl chr10:79,610,939...79,615,455
|
|
G |
SFTPB |
surfactant protein B |
|
IEP ISO |
associated with Cystic Fibrosis;protein:increased expression:lung |
RGD |
PMID:15271694 PMID:12169586 |
RGD:4143403, RGD:4143464 |
NCBI chr 2:85,657,307...85,668,741
Ensembl chr 2:85,657,314...85,668,741
|
|
G |
SFTPC |
surfactant protein C |
|
ISO |
|
RGD |
PMID:18566429 PMID:12169586 |
RGD:4144114, RGD:4143464 |
NCBI chr 8:22,157,383...22,164,479
Ensembl chr 8:22,156,913...22,164,479
|
|
G |
SFTPD |
surfactant protein D |
|
ISO IEP |
protein:increased expression:lung associated with Cystic Fibrosis;protein:decreased expression:lung |
RGD |
PMID:12169586 PMID:15271694 |
RGD:4143464, RGD:4143403 |
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
|
ISO |
|
RGD |
PMID:18192501 |
RGD:6892945 |
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
severity |
ISO |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:18768871 PMID:19844782 |
RGD:4145337, RGD:4889533 |
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
|
|
G |
TLR4 |
toll like receptor 4 |
|
ISO |
|
RGD |
PMID:20650991 PMID:16210672 |
RGD:4144172, RGD:4144197 |
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TLR5 |
toll like receptor 5 |
|
ISO |
|
RGD |
PMID:19801452 |
RGD:5129503 |
NCBI chr 1:223,109,404...223,143,248
Ensembl chr 1:223,109,404...223,143,292
|
|
G |
TLR6 |
toll like receptor 6 |
|
ISO |
|
RGD |
PMID:19844782 |
RGD:4889533 |
NCBI chr 4:38,822,897...38,868,390
Ensembl chr 4:38,822,897...38,856,817
|
|
G |
TLR9 |
toll like receptor 9 |
|
ISO |
|
RGD |
PMID:20360853 |
RGD:5130719 |
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
|
|
G |
TNF |
tumor necrosis factor |
disease_progression treatment severity |
IEP IDA ISO |
associated with Agranulocytosis |
RGD |
PMID:10650487 PMID:7546648 PMID:9310939 PMID:12958055 |
RGD:4143476, RGD:10755357, RGD:10450564, RGD:10449451 |
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased expression:serum (mouse) |
RGD |
PMID:19842848 |
RGD:5131429 |
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
|
|
G |
TNFRSF1B |
TNF receptor superfamily member 1B |
|
ISO |
protein:increased expression:serum (mouse) |
RGD |
PMID:19842848 |
RGD:5131429 |
NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228
|
|
G |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
severity ameliorates |
IEP ISO |
|
RGD |
PMID:24465168 PMID:16960786 PMID:22996209 |
RGD:126848796, RGD:127229902, RGD:126925987 |
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,100...41,286,682
|
|
G |
ZC3H12A |
zinc finger CCCH-type containing 12A |
|
ISO |
associated with Pseudomonas Infections |
RGD |
PMID:29695841 |
RGD:39938967 |
NCBI chr 1:37,474,580...37,484,377
Ensembl chr 1:37,474,580...37,484,377
|
|
|
G |
ADRB2 |
adrenoceptor beta 2 |
|
IDA |
|
RGD |
PMID:17687719 |
RGD:4145098 |
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
|
|
G |
CCL11 |
C-C motif chemokine ligand 11 |
severity |
IEP ISO |
protein:increased expression:nasal mucus associated with Respiratory Syncytial Virus Infections |
RGD |
PMID:17297249 PMID:15681407 |
RGD:4145460, RGD:4145415 |
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
|
|
G |
CD40 |
CD40 molecule |
|
IEP |
|
RGD |
PMID:19470255 |
RGD:5132271 |
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
|
|
G |
CD86 |
CD86 molecule |
|
ISO |
protein:decreased expression:myeloid dendritic cell (mouse) |
RGD |
PMID:20046053 |
RGD:4892291 |
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
|
|
G |
CRP |
C-reactive protein |
severity |
IEP |
|
RGD |
PMID:21284715 |
RGD:5131282 |
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
|
|
G |
CYSLTR1 |
cysteinyl leukotriene receptor 1 |
|
ISO |
associated with Pneumovirus Infections |
RGD |
PMID:16337014 |
RGD:4843953 |
NCBI chr X:78,271,468...78,327,611
Ensembl chr X:78,271,468...78,327,691
|
|
G |
IL17A |
interleukin 17A |
susceptibility |
IAGP |
DNA:SNP:promoter:rs2275913 (human) |
RGD |
PMID:20437253 |
RGD:4889139 |
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL1B |
interleukin 1 beta |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:8608647 |
RGD:4143192 |
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:8608647 |
RGD:4143192 |
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
|
|
G |
MUC5B |
mucin 5B, oligomeric mucus/gel-forming |
|
IAGP |
DNA:polymorphisms:promoter:rs885454,rs17235353, rs7115457 (human) |
RGD |
PMID:15709052 |
RGD:7349353 |
NCBI chr11:1,223,066...1,262,172
Ensembl chr11:1,223,066...1,262,172
|
|
|
G |
ACE |
angiotensin I converting enzyme |
|
ISO |
|
RGD |
PMID:17097496 |
RGD:4140933 |
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
|
|
G |
ADORA2A |
adenosine A2a receptor |
|
ISO |
|
RGD |
PMID:19766783 |
RGD:4890362 |
NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357
|
|
G |
CCL17 |
C-C motif chemokine ligand 17 |
|
IEP |
|
RGD |
PMID:18785972 |
RGD:4145604 |
NCBI chr16:57,396,093...57,416,063
Ensembl chr16:57,404,767...57,416,063
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO |
|
RGD |
PMID:14611812 |
RGD:2307195 |
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL22 |
C-C motif chemokine ligand 22 |
|
IEP |
|
RGD |
PMID:20628341 |
RGD:4891471 |
NCBI chr16:57,357,909...57,366,189
Ensembl chr16:57,358,783...57,366,189
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
mRNA:increased expression:lung (rat) |
RGD |
PMID:19840961 PMID:14611812 |
RGD:4889978, RGD:2307195 |
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
|
ISO |
protein:increased expression:bronchoalveolar Lavage fluid |
RGD |
PMID:22215510 |
RGD:6483763 |
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO |
mRNA:increased expression:trachea: |
RGD |
PMID:11518728 |
RGD:4145124 |
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
|
|
G |
CD86 |
CD86 molecule |
|
ISO |
|
RGD |
PMID:11266944 |
RGD:2307206 |
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
|
|
G |
CSF2 |
colony stimulating factor 2 |
|
ISO |
associated with Respiratory Aspiration;protein:increased expression:serum |
RGD |
PMID:18557728 |
RGD:2317286 |
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO IEP |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:16709871 PMID:12097412 PMID:12097412 |
RGD:5135441, RGD:5135451, RGD:5135451 |
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
CXCL11 |
C-X-C motif chemokine ligand 11 |
|
ISO IEP |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:12097412 PMID:12097412 |
RGD:5135451, RGD:5135451 |
NCBI chr 4:76,033,682...76,036,070
Ensembl chr 4:76,033,682...76,041,415
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO IEP |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:16709871 PMID:12097412 PMID:12097412 |
RGD:5135441, RGD:5135451, RGD:5135451 |
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:16709871 PMID:12097412 |
RGD:5135441, RGD:5135451 |
NCBI chr X:71,615,919...71,618,511
Ensembl chr X:71,615,916...71,618,511
|
|
G |
EDN1 |
endothelin 1 |
|
IMP |
human gene in a rat model |
RGD |
PMID:9595474 |
RGD:8662402 |
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
FOXP3 |
forkhead box P3 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19840961 |
RGD:4889978 |
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800
|
|
G |
GZMB |
granzyme B |
|
IEP |
|
RGD |
PMID:19737140 |
RGD:5135518 |
NCBI chr14:24,630,954...24,634,190
Ensembl chr14:24,630,954...24,634,267
|
|
G |
HMOX1 |
heme oxygenase 1 |
|
ISO |
|
RGD |
PMID:12973103 |
RGD:4145412 |
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
IFNG |
interferon gamma |
|
EXP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16137903 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL13 |
interleukin 13 |
|
ISO IEP |
protein:increased expression:bronchoalveolar lavage fluid |
RGD |
PMID:17182591 PMID:17182591 |
RGD:4146242, RGD:4146242 |
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
|
|
G |
IL13RA1 |
interleukin 13 receptor subunit alpha 1 |
|
ISO |
|
RGD |
PMID:17182591 |
RGD:4146242 |
NCBI chr X:118,727,606...118,805,228
Ensembl chr X:118,727,133...118,794,535
|
|
G |
IL13RA2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
|
RGD |
PMID:17182591 |
RGD:4146242 |
NCBI chr X:115,003,982...115,017,616
Ensembl chr X:115,003,975...115,019,977
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
mRNA:increased expression:trachea |
RGD |
PMID:20393404 |
RGD:4143277 |
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:11889437 |
RGD:4143176 |
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:18557728 |
RGD:2317286 |
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
|
RGD |
PMID:20393404 |
RGD:4143277 |
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
MBL2 |
mannose binding lectin 2 |
resistance |
IAGP |
DNA:transversion:5' utr:-290C>G rs7096206 (human) |
RGD |
PMID:19104434 |
RGD:4889456 |
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
IEP |
protein:increased expression, increased activity:bronchoalveolar lavage fluid |
RGD |
PMID:20417130 |
RGD:5130759 |
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MUC1 |
mucin 1, cell surface associated |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:16969297 |
RGD:5131273 |
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
|
IAGP |
|
RGD |
PMID:18158963 |
RGD:5131450 |
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
IEP |
associated with lung transplantation; protein:increased expression:lung |
RGD |
PMID:11112135 |
RGD:4892082 |
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:15136885 |
RGD:4892068 |
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
SCGB1A1 |
secretoglobin family 1A member 1 |
|
IEP |
associated with lung transplantation; protein:decreased expression:serum,bronchoalveolar lavage |
RGD |
PMID:11981419 |
RGD:5147386 |
NCBI chr11:62,419,033...62,423,195
Ensembl chr11:62,405,103...62,423,195
|
|
G |
SFTPD |
surfactant protein D |
|
IEP |
|
RGD |
PMID:18347569 |
RGD:4143500 |
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
|
|
G |
TLR9 |
toll like receptor 9 |
|
IAGP |
DNA:SNPs:promoter, 3' utr:g.-1485C>T (rs187084), rs352162 (human) |
RGD |
PMID:20227302 |
RGD:5130722 |
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
|
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
|
IAGP |
DNA:polymorphism (human) |
RGD |
PMID:14593914 |
RGD:4889126 |
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
EGR1 |
early growth response 1 |
|
ISO |
|
RGD |
PMID:17384085 |
RGD:5132266 |
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
G |
HDAC2 |
histone deacetylase 2 |
treatment |
ISO |
|
RGD |
PMID:22708526 |
RGD:9590258 |
NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308
|
|
G |
IFNG |
interferon gamma |
resistance |
ISO |
|
RGD |
PMID:20953328 |
RGD:4145525 |
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
IEP |
protein:increased secretion:serum (human) |
RGD |
PMID:20350425 |
RGD:4892019 |
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CXCR2 |
C-X-C motif chemokine receptor 2 |
disease_progression |
ISO |
associated with Plague |
RGD |
PMID:21356370 |
RGD:5134954 |
NCBI chr 2:218,125,294...218,137,251
Ensembl chr 2:218,125,289...218,137,251
|
|
G |
MBL2 |
mannose binding lectin 2 |
|
IEP |
associated with Down Syndrome; protein:decreased secretion:serum (human) |
RGD |
PMID:19804807 |
RGD:4889483 |
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
|
|
|
G |
CD274 |
CD274 molecule |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566
|
|
G |
PDCD1 |
programmed cell death 1 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chr 2:241,849,884...241,858,894
Ensembl chr 2:241,849,884...241,858,894
|
|
G |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
severity |
ISO |
|
RGD |
PMID:29893841 |
RGD:40890270 |
NCBI chr 1:9,627,258...9,729,114
Ensembl chr 1:9,629,889...9,729,114
|
|
|
G |
CCL11 |
C-C motif chemokine ligand 11 |
|
IEP |
|
RGD |
PMID:11991282 |
RGD:4145442 |
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
|
|
G |
CFTR |
CF transmembrane conductance regulator |
susceptibility |
IAGP |
associated with pulmonary disease chronic obstructive; DNA:missense mutation:exon:p.R75Q(human) DNA:deletion: :F508del(human) |
RGD |
PMID:15463907 PMID:10767489 |
RGD:4140475, RGD:4140484 |
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
|
|
G |
CTLA4 |
cytotoxic T-lymphocyte associated protein 4 |
|
IAGP |
DNA:SNPs: :multiple (human) |
RGD |
PMID:19386687 |
RGD:4891509 |
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
susceptibility |
IAGP |
DNA:polymorphism (human) |
RGD |
PMID:15928955 |
RGD:4142512 |
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
|
IAGP |
DNA:polymorphism (human) |
RGD |
PMID:14593914 |
RGD:4889126 |
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
EDN1 |
endothelin 1 |
|
ISO |
Chronic Allergic Airway Inflammation; protein:increased secretion:bronchoalveolar lavage (mouse) |
RGD |
PMID:18631350 |
RGD:4145074 |
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
GC |
GC vitamin D binding protein |
susceptibility |
IAGP |
|
RGD |
PMID:12096683 |
RGD:5129516 |
NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
|
|
G |
GSTM1 |
glutathione S-transferase mu 1 |
severity |
IAGP |
DNA:deletion: : DNA:deletion, haplotype: : (human) |
RGD |
PMID:9187680 PMID:15125256 |
RGD:4142513, RGD:12798508 |
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
|
|
G |
GSTT1 |
glutathione S-transferase theta 1 |
susceptibility |
IAGP |
DNA:deletion: : |
RGD |
PMID:15928955 |
RGD:4142512 |
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased expression:bronchial epithelium (rat) |
RGD |
PMID:19507274 |
RGD:2308951 |
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IL10 |
interleukin 10 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:19507274 |
RGD:2308951 |
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL13 |
interleukin 13 |
|
IEP |
protein:increased expression:Respiratory Mucosa |
RGD |
PMID:14582911 |
RGD:4759835 |
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
|
|
G |
IL15 |
interleukin 15 |
|
IEP |
mRNA, protein:increased expression:lung |
RGD |
PMID:11742275 |
RGD:4990461 |
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
|
|
G |
MPO |
myeloperoxidase |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11798689 |
RGD:5130990 |
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
|
RGD |
PMID:19938219 |
RGD:4891494 |
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NPY |
neuropeptide Y |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9731035 |
|
NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862
|
|
G |
VEGFA |
vascular endothelial growth factor A |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19263519 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
|
G |
EDN1 |
endothelin 1 |
|
IEP |
protein:increased expression:inferior turbinate, nasal gland, inflammatory cell (human) |
RGD |
PMID:8845175 |
RGD:8661738 |
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
|
G |
CD8A |
CD8 subunit alpha |
ameliorates |
IEP |
protein:decreased expression:blood, T cell (human) |
RGD |
PMID:24639246 |
RGD:124715444 |
NCBI chr 2:86,784,605...86,808,396
Ensembl chr 2:86,784,610...86,808,396
|
|
G |
IL17A |
interleukin 17A |
|
IEP |
protein:increased expression:uncinate process, nasal mucosa (human) |
RGD |
PMID:23613503 |
RGD:8696039 |
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
susceptibility |
IAGP |
DNA:repeats:intron:IVS2+914_1000dup I/II alleles (human) |
RGD |
PMID:16549749 |
RGD:8549791 |
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
|
|
G |
MBL2 |
mannose binding lectin 2 |
|
IEP |
protein:decreased activity:serum: |
RGD |
PMID:23144819 |
RGD:8693716 |
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
|
|
G |
PRG2 |
proteoglycan 2, pro eosinophil major basic protein |
disease_progression |
IEP |
associated with Nasal Polyps; |
RGD |
PMID:24450586 |
RGD:13506943 |
NCBI chr11:57,386,780...57,390,650
Ensembl chr11:57,386,780...57,390,650
|
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
IEP |
protein:increased expression:bronchus |
RGD |
PMID:11865407 |
RGD:4890421 |
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
|
|
G |
ALOX5AP |
arachidonate 5-lipoxygenase activating protein |
|
IEP |
protein:increased expression:bronchus |
RGD |
PMID:11865407 |
RGD:4890421 |
NCBI chr13:30,713,485...30,764,426
Ensembl chr13:30,713,478...30,764,426
|
|
G |
CX3CL1 |
C-X3-C motif chemokine ligand 1 |
|
IDA |
|
RGD |
PMID:20696083 |
RGD:4140458 |
NCBI chr16:57,372,490...57,385,044
Ensembl chr16:57,372,477...57,385,044
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
|
IEP |
associated with Pulmonary Disease, Chronic Obstructive;protein:increased expression:respiratory epithelial cell |
RGD |
PMID:20395558 |
RGD:4145446 |
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
IEP |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:15764644 |
RGD:5135489 |
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
CXCL5 |
C-X-C motif chemokine ligand 5 |
|
IEP |
associated with Asthma |
RGD |
PMID:12751040 |
RGD:5135264 |
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
treatment |
IEP |
|
RGD |
PMID:28343401 |
RGD:150521550 |
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CXCR2 |
C-X-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:19864593 |
RGD:5131210 |
NCBI chr 2:218,125,294...218,137,251
Ensembl chr 2:218,125,289...218,137,251
|
|
G |
DEFB4A |
defensin beta 4A |
|
IEP |
mRNA, protein:increased expression:nasal cavity epithelium, nasal mucus |
RGD |
PMID:15034083 |
RGD:4892264 |
NCBI chr 8:7,894,677...7,896,716
Ensembl chr 8:7,894,677...7,896,716 Ensembl chr 8:7,894,677...7,896,716
|
|
G |
IFNA2 |
interferon alpha 2 |
treatment |
IDA |
|
RGD |
PMID:6381610 |
RGD:40886344 |
NCBI chr 9:21,384,255...21,385,398
Ensembl chr 9:21,384,255...21,385,398
|
|
G |
IL10 |
interleukin 10 |
|
IDA |
|
RGD |
PMID:20696083 |
RGD:4140458 |
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL1A |
interleukin 1 alpha |
|
IEP |
protein:increased expression:nasal mucus |
RGD |
PMID:10358201 |
RGD:4143183 |
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
|
IEP |
protein:increased expression:nasal mucus |
RGD |
PMID:7734976 |
RGD:7401200 |
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
IEP IDA |
protein:increased expression:nasal mucus |
RGD |
PMID:10358201 PMID:18279051 |
RGD:4143183, RGD:4143207 |
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
|
|
G |
IL33 |
interleukin 33 |
|
IEP |
protein:increased expression:nasal mucus |
RGD |
PMID:28471975 |
RGD:38596342 |
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
associated with Asthma;mRNA, protein:increased expression:alveolar macrophage, respiratory system fluid/secretion |
RGD |
PMID:20644177 |
RGD:4140459 |
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
PRDX5 |
peroxiredoxin 5 |
|
IEP |
associated with asthma;protein:increased expression:sputum (human) |
RGD |
PMID:18219526 |
RGD:41404684 |
NCBI chr11:64,318,121...64,321,811
Ensembl chr11:64,318,121...64,321,811
|
|
G |
TSLP |
thymic stromal lymphopoietin |
|
IEP |
protein:increased expression:nasal mucus (human) |
RGD |
PMID:28471975 |
RGD:38596342 |
NCBI chr 5:111,070,062...111,078,026
Ensembl chr 5:111,070,062...111,078,026
|
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
|
IEP |
protein:increased expression:lung, macrophage (human) |
RGD |
PMID:21144722 |
RGD:5131112 |
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
|
|
G |
TNFRSF1B |
TNF receptor superfamily member 1B |
|
IEP |
protein:increased expression:lung, lymphocyte (human) |
RGD |
PMID:21144722 |
RGD:5131112 |
NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228
|
|
|
G |
SFTPC |
surfactant protein C |
|
ISS |
OMIM:263000 |
MouseDO |
|
|
NCBI chr 8:22,157,383...22,164,479
Ensembl chr 8:22,156,913...22,164,479
|
|
|
G |
HLA-B |
major histocompatibility complex, class I, B |
susceptibility |
IAGP |
DNA:polymorphism:cds:HLA-B*5401 (human) |
RGD |
PMID:9731015 |
RGD:1331522 |
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
IAGP |
DNA:SNP:exon:p.G54D(rs1800450)(human) |
RGD |
PMID:15249448 |
RGD:8693755 |
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
|
|
G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
|
IEP |
protein:decreased expression:bronchiole epithelium |
RGD |
PMID:15364771 |
RGD:7364741 |
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
|
|
G |
MUC5B |
mucin 5B, oligomeric mucus/gel-forming |
|
IAGP |
DNA:insertion/deletion |
RGD |
PMID:15709052 |
RGD:7349353 |
NCBI chr11:1,223,066...1,262,172
Ensembl chr11:1,223,066...1,262,172
|
|
G |
MUCL3 |
mucin like 3 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22152429 |
|
NCBI chr 6:30,940,973...30,954,221
Ensembl chr 6:30,934,523...30,954,221
|
|
G |
TAP2 |
transporter 2, ATP binding cassette subfamily B member |
susceptibility |
IAGP |
DNA:polymorphisms:exon: |
RGD |
PMID:10323341 |
RGD:5147847 |
NCBI chr 6:32,821,831...32,838,739
Ensembl chr 6:32,821,833...32,838,739
|
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
|
IEP |
protein:increased expression:ethmoid sinus |
RGD |
PMID:9800627 |
RGD:6483785 |
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
|
|
|
G |
C5 |
complement C5 |
|
ISO |
|
RGD |
PMID:2612053 |
RGD:5130160 |
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
|
ISO |
|
RGD |
PMID:20045013 |
RGD:5129686 |
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
|
|
G |
GATA2 |
GATA binding protein 2 |
|
ISO |
associated with Pneumocystis Infections |
RGD |
PMID:16774119 |
RGD:9587813 |
NCBI chr 3:128,479,422...128,493,201
Ensembl chr 3:128,479,427...128,493,201
|
|
G |
IL13 |
interleukin 13 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:19752036 PMID:16544260 |
RGD:4145474, RGD:4145506 |
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
|
|
G |
IL33 |
interleukin 33 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:25746970 |
RGD:39938968 |
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:10639453 |
RGD:4891455 |
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
SFTPA1 |
surfactant protein A1 |
susceptibility |
ISO |
|
RGD |
PMID:20413160 |
RGD:4143489 |
NCBI chr10:79,610,939...79,615,455
Ensembl chr10:79,610,939...79,615,455
|
|
G |
SFTPD |
surfactant protein D |
susceptibility |
ISO IDA |
|
RGD |
PMID:20413160 PMID:20413160 |
RGD:4143489, RGD:4143489 |
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:16544260 |
RGD:4145506 |
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
|
G |
ABO |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
susceptibility |
IAGP |
DNA:polymorphism:cds:allele AB (human) |
RGD |
PMID:6189297 PMID:4375858 |
RGD:5128836, RGD:39938844 |
NCBI chr 9:133,250,401...133,275,201
Ensembl chr 9:133,233,278...133,276,024
|
|
G |
APOL6 |
apolipoprotein L6 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr22:35,648,446...35,668,404
Ensembl chr22:35,648,446...35,668,404
|
|
G |
ATF3 |
activating transcription factor 3 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:21408070 |
RGD:5129492 |
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
|
|
G |
CASP1 |
caspase 1 |
|
ISO |
|
RGD |
PMID:19362023 |
RGD:5130181 |
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CAT |
catalase |
|
ISO IDA |
|
RGD |
PMID:16804020 PMID:20653246 PMID:19959187 |
RGD:5130864, RGD:5130201, RGD:5130744 |
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL11 |
C-C motif chemokine ligand 11 |
|
ISO |
associated with Asthma;protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:12707338 PMID:20656925 |
RGD:4145439, RGD:4145452 |
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO EXP |
mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23326326 PMID:20967263 |
RGD:4891425 |
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL28 |
C-C motif chemokine ligand 28 |
resistance |
ISO |
|
RGD |
PMID:19847203 |
RGD:4892196 |
NCBI chr 5:43,356,975...43,412,391
Ensembl chr 5:43,376,645...43,412,391
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
susceptibility |
ISO |
protein:increased expression:lung (mouse) |
RGD |
PMID:20656925 PMID:16208318 |
RGD:4145452, RGD:4892131 |
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CCL8 |
C-C motif chemokine ligand 8 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr17:34,319,435...34,321,402
Ensembl chr17:34,319,435...34,321,402
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
severity |
ISO IAGP |
DNA:frameshift mutation:cds:p.S185_T195del rs333 (human) |
RGD |
PMID:19039768 PMID:18617426 PMID:20875295 |
RGD:4892119, RGD:4892122, RGD:4892063 |
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
|
|
G |
CD14 |
CD14 molecule |
|
ISO |
|
RGD |
PMID:17825924 |
RGD:4144809 |
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
|
|
G |
CD209 |
CD209 molecule |
susceptibility |
IEP |
|
RGD |
PMID:21191006 |
RGD:5131189 |
NCBI chr19:7,739,993...7,747,534
Ensembl chr19:7,739,993...7,747,564
|
|
G |
CD28 |
CD28 molecule |
|
ISO |
|
RGD |
PMID:21389258 |
RGD:5131611 |
NCBI chr 2:203,706,482...203,738,912
Ensembl chr 2:203,706,517...203,739,756
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:19922665 |
RGD:5132270 |
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
|
|
G |
CD80 |
CD80 molecule |
|
ISO |
|
RGD |
PMID:19922665 PMID:10604996 |
RGD:5132270, RGD:5132623 |
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
|
|
G |
CD86 |
CD86 molecule |
|
ISO |
protein:increased expression:mediastinal lymph node, B cell (mouse) |
RGD |
PMID:19933871 |
RGD:4892570 |
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
|
|
G |
CRP |
C-reactive protein |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:21509252 |
RGD:5131277 |
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
|
|
G |
CSF2 |
colony stimulating factor 2 |
|
ISO IDA |
|
RGD |
PMID:21474645 PMID:20427198 |
RGD:5131470, RGD:5131472 |
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion protein:increased expression:lung, serum |
RGD |
PMID:20656925 PMID:17348295 |
RGD:4145452, RGD:4145366 |
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:21251691 PMID:20967263 |
RGD:5135026, RGD:4891425 |
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
DDX60 |
DExD/H-box helicase 60 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 4:168,216,294...168,325,979
Ensembl chr 4:168,216,291...168,318,883
|
|
G |
EGR1 |
early growth response 1 |
|
ISO |
mRNA:increased expression:frontal cortex (mouse) |
RGD |
PMID:21289196 |
RGD:5131660 |
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
G |
EIF2AK2 |
eukaryotic translation initiation factor 2 alpha kinase 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 2:37,099,210...37,156,980
Ensembl chr 2:37,099,210...37,157,522
|
|
G |
FOXP2 |
forkhead box P2 |
|
ISO |
|
RGD |
PMID:18248790 |
RGD:11536002 |
NCBI chr 7:114,086,327...114,693,765
Ensembl chr 7:114,086,327...114,693,772
|
|
G |
GBP1 |
guanylate binding protein 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:89,052,319...89,065,208
Ensembl chr 1:89,051,882...89,065,360
|
|
G |
HERC5 |
HECT and RLD domain containing E3 ubiquitin protein ligase 5 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 4:88,457,119...88,506,163
Ensembl chr 4:88,457,119...88,506,163
|
|
G |
HERC6 |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 4:88,378,852...88,443,097
Ensembl chr 4:88,378,739...88,443,097
|
|
G |
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1 |
|
IMP |
|
RGD |
PMID:19386707 |
RGD:4144816 |
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
|
|
G |
HLA-G |
major histocompatibility complex, class I, G |
|
IEP |
|
RGD |
PMID:21087648 |
RGD:5144131 |
NCBI chr 6:29,826,474...29,831,021
Ensembl chr 6:29,826,967...29,831,125
|
|
G |
IFI27 |
interferon alpha inducible protein 27 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr14:94,105,894...94,116,690
Ensembl chr14:94,104,836...94,116,695
|
|
G |
IFI35 |
interferon induced protein 35 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr17:43,006,784...43,014,456
Ensembl chr17:43,006,740...43,014,456
|
|
G |
IFI44 |
interferon induced protein 44 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:78,649,789...78,664,078
Ensembl chr 1:78,649,796...78,664,078
|
|
G |
IFI44L |
interferon induced protein 44 like |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:78,620,448...78,646,145
Ensembl chr 1:78,619,902...78,646,145
|
|
G |
IFI6 |
interferon alpha inducible protein 6 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:27,666,064...27,672,192
Ensembl chr 1:27,666,064...27,672,212
|
|
G |
IFIH1 |
interferon induced with helicase C domain 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 2:162,267,074...162,318,684
Ensembl chr 2:162,267,074...162,318,684
|
|
G |
IFIT1 |
interferon induced protein with tetratricopeptide repeats 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr10:89,392,623...89,406,487
Ensembl chr10:89,392,546...89,406,487
|
|
G |
IFIT2 |
interferon induced protein with tetratricopeptide repeats 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr10:89,302,046...89,309,271
Ensembl chr10:89,283,694...89,309,271
|
|
G |
IFIT3 |
interferon induced protein with tetratricopeptide repeats 3 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr10:89,327,997...89,340,968
Ensembl chr10:89,327,307...89,377,473
|
|
G |
IFIT5 |
interferon induced protein with tetratricopeptide repeats 5 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr10:89,414,568...89,420,997
Ensembl chr10:89,414,568...89,421,605
|
|
G |
IFITM3 |
interferon induced transmembrane protein 3 |
susceptibility |
EXP IAGP |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Influenza, severe, susceptibility to |
CTD ClinVar OMIM |
PMID:20943977 PMID:22446628 PMID:23326326 |
|
NCBI chr11:319,676...320,860
Ensembl chr11:319,676...329,475
|
|
G |
IL10 |
interleukin 10 |
susceptibility |
ISO |
|
RGD |
PMID:20200252 |
RGD:4140426 |
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL12B |
interleukin 12B |
|
ISO |
|
RGD |
PMID:16389596 |
RGD:4145426 |
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
G |
IL13 |
interleukin 13 |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:20003352 |
RGD:4888530 |
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
|
|
G |
IL15 |
interleukin 15 |
|
IMP ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:19234203 PMID:21098221 PMID:20212069 |
RGD:4996472, RGD:4994196, RGD:4996471 |
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
|
|
G |
IL15RA |
interleukin 15 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:21098221 |
RGD:4994196 |
NCBI chr10:5,948,900...5,978,741
Ensembl chr10:5,943,639...5,978,187
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:19783685 PMID:19265125 |
RGD:4889102, RGD:4889150 |
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL17RA |
interleukin 17 receptor A |
|
ISO |
|
RGD |
PMID:19783685 |
RGD:4889102 |
NCBI chr22:17,085,000...17,115,693
Ensembl chr22:17,084,954...17,115,693
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:15606801 |
RGD:4889964 |
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096
|
|
G |
IL1A |
interleukin 1 alpha |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11535264 |
RGD:4142860 |
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO |
|
RGD |
PMID:20438620 |
RGD:4142822 |
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
disease_progression |
IEP IDA |
protein:increased expression:serum |
RGD |
PMID:20840779 PMID:9439800 |
RGD:4143203, RGD:4143228 |
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
|
|
G |
IL2 |
interleukin 2 |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:21603856 |
RGD:5147905 |
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
|
|
G |
IL22 |
interleukin 22 |
|
ISO |
|
RGD |
PMID:21178015 PMID:20504940 |
RGD:5147404, RGD:5147405 |
NCBI chr12:68,248,242...68,253,604
Ensembl chr12:68,248,242...68,253,604
|
|
G |
IL4 |
interleukin 4 |
|
ISO |
|
RGD |
PMID:21092162 |
RGD:5128546 |
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
|
RGD |
PMID:20731583 |
RGD:4143268 |
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
IRF7 |
interferon regulatory factor 7 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr11:612,555...615,950
Ensembl chr11:612,553...615,983
|
|
G |
ISG15 |
ISG15 ubiquitin like modifier |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:1,013,497...1,014,540
Ensembl chr 1:1,001,138...1,014,540
|
|
G |
LAMP3 |
lysosomal associated membrane protein 3 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 3:183,122,215...183,163,813
Ensembl chr 3:183,122,215...183,163,839
|
|
G |
LY6E |
lymphocyte antigen 6 family member E |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 8:143,018,529...143,022,409
Ensembl chr 8:143,017,982...143,023,832
|
|
G |
LYST |
lysosomal trafficking regulator |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26597256 |
|
NCBI chr 1:235,661,031...235,883,713
Ensembl chr 1:235,661,041...235,883,724
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased activity:lung, heart, brain |
RGD |
PMID:20299740 |
RGD:5130855 |
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MX1 |
MX dynamin like GTPase 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr21:41,420,558...41,459,214
Ensembl chr21:41,420,020...41,470,071
|
|
G |
MX2 |
MX dynamin like GTPase 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr21:41,362,027...41,409,393
Ensembl chr21:41,361,999...41,409,393
|
|
G |
NOS1 |
nitric oxide synthase 1 |
|
ISO |
protein:increased expression:hippocampus |
RGD |
PMID:9552178 |
RGD:5132870 |
NCBI chr12:117,208,142...117,361,626
Ensembl chr12:117,208,142...117,452,170
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
mRNA:increased expression:olfactory epithelium mRNA,protein:increased expression:brain |
RGD |
PMID:17674769 PMID:18080188 PMID:17030871 |
RGD:4891919, RGD:4891937, RGD:4891952 |
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
OAS1 |
2'-5'-oligoadenylate synthetase 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr12:112,906,962...112,933,219
Ensembl chr12:112,905,856...112,933,219
|
|
G |
OAS2 |
2'-5'-oligoadenylate synthetase 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr12:112,978,519...113,011,723
Ensembl chr12:112,978,395...113,011,723
|
|
G |
OAS3 |
2'-5'-oligoadenylate synthetase 3 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr12:112,938,474...112,973,251
Ensembl chr12:112,938,051...112,976,460
|
|
G |
OASL |
2'-5'-oligoadenylate synthetase like |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr12:121,017,761...121,039,246
Ensembl chr12:121,017,763...121,039,246
|
|
G |
PARP12 |
poly(ADP-ribose) polymerase family member 12 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 7:140,023,749...140,062,951
Ensembl chr 7:140,023,749...140,062,951
|
|
G |
PLSCR1 |
phospholipid scramblase 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 3:146,515,180...146,544,607
Ensembl chr 3:146,515,180...146,544,856
|
|
G |
PRF1 |
perforin 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26597256 |
|
NCBI chr10:70,597,348...70,602,741
Ensembl chr10:70,597,348...70,602,759
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
|
RGD |
PMID:16272346 |
RGD:5143925 |
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RIGI |
RNA sensor RIG-I |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 9:32,455,302...32,526,196
Ensembl chr 9:32,455,302...32,526,348
|
|
G |
RSAD2 |
radical S-adenosyl methionine domain containing 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 2:6,865,885...6,898,239
Ensembl chr 2:6,865,557...6,898,239
|
|
G |
RTP4 |
receptor transporter protein 4 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 3:187,368,385...187,372,076
Ensembl chr 3:187,368,385...187,372,076
|
|
G |
SAMD9 |
sterile alpha motif domain containing 9 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 7:93,099,518...93,117,979
Ensembl chr 7:93,099,513...93,118,023
|
|
G |
SCO2 |
synthesis of cytochrome C oxidase 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr22:50,523,568...50,526,442
Ensembl chr22:50,523,568...50,526,461
|
|
G |
SERPING1 |
serpin family G member 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr11:57,597,685...57,614,848
Ensembl chr11:57,597,387...57,619,171
|
|
G |
SFTPD |
surfactant protein D |
|
ISO |
|
RGD |
PMID:16787926 |
RGD:4143518 |
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
|
|
G |
SIGLEC1 |
sialic acid binding Ig like lectin 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr20:3,686,970...3,712,600
Ensembl chr20:3,686,970...3,712,600
|
|
G |
SLC22A8 |
solute carrier family 22 member 8 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23129053 |
|
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
|
|
G |
STAT1 |
signal transducer and activator of transcription 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
|
|
G |
TDRD7 |
tudor domain containing 7 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 9:97,412,096...97,496,125
Ensembl chr 9:97,412,096...97,496,125
|
|
G |
TLR2 |
toll like receptor 2 |
|
IEP |
protein:increased expression:monocyte |
RGD |
PMID:18657324 |
RGD:4145339 |
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
|
|
G |
TLR3 |
toll like receptor 3 |
|
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:16789835 PMID:18654661 |
RGD:5129219, RGD:5129136 |
NCBI chr 4:186,069,156...186,088,073
Ensembl chr 4:186,068,911...186,088,073
|
|
G |
TMPRSS11D |
transmembrane serine protease 11D |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20237084 PMID:23072892 |
|
NCBI chr 4:67,820,876...67,884,002
Ensembl chr 4:67,820,876...67,884,002
|
|
G |
TMPRSS2 |
transmembrane serine protease 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:20237084 PMID:21123387 PMID:23072892 PMID:26889029 PMID:28778717 PMID:31391268 More...
|
|
NCBI chr21:41,464,305...41,508,158
Ensembl chr21:41,464,300...41,531,116
|
|
G |
TMPRSS4 |
transmembrane serine protease 4 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26889029 |
|
NCBI chr11:118,077,078...118,125,505
Ensembl chr11:118,077,012...118,125,510
|
|
G |
TNF |
tumor necrosis factor |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:21062445 |
RGD:5128683 |
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFAIP6 |
TNF alpha induced protein 6 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 2:151,357,592...151,381,340
Ensembl chr 2:151,357,592...151,380,046
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
|
ISO IEP |
protein:increased expression:serum (human) |
RGD |
PMID:17182684 PMID:19497758 |
RGD:5131157, RGD:5131432 |
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
|
|
G |
TNFSF10 |
TNF superfamily member 10 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
|
|
G |
TOR1B |
torsin family 1 member B |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 9:129,803,184...129,811,281
Ensembl chr 9:129,803,157...129,811,281
|
|
G |
TREX1 |
three prime repair exonuclease 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 3:48,465,830...48,467,645
Ensembl chr 3:48,465,811...48,467,645
|
|
G |
TRIM22 |
tripartite motif containing 22 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr11:5,689,790...5,710,863
Ensembl chr11:5,689,610...5,737,089
|
|
G |
UBE2L6 |
ubiquitin conjugating enzyme E2 L6 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr11:57,551,662...57,567,935
Ensembl chr11:57,551,656...57,568,284
|
|
G |
UGCG |
UDP-glucose ceramide glucosyltransferase |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33639165 |
|
NCBI chr 9:111,896,814...111,935,369
Ensembl chr 9:111,896,814...111,935,369
|
|
G |
XAF1 |
XIAP associated factor 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr17:6,755,447...6,775,647
Ensembl chr17:6,755,447...6,775,647
|
|
G |
XIST |
X inactive specific transcript |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr X:73,820,656...73,852,714
Ensembl chr X:73,820,649...73,852,723
|
|
G |
ZCCHC2 |
zinc finger CCHC-type containing 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr18:62,523,025...62,586,729
Ensembl chr18:62,523,025...62,587,709
|
|
|
G |
CXCL5 |
C-X-C motif chemokine ligand 5 |
|
IEP |
associated with Scleroderma, Diffuse protein:increased expression:serum |
RGD |
PMID:18432520 PMID:16085216 |
RGD:5135258, RGD:5135260 |
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
IEP |
protein:increased expression:lung, alveolar macrophage (human) |
RGD |
PMID:19218648 |
RGD:4145518 |
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
protein:increased expression:bronchoalveolar lavage (rat) |
RGD |
PMID:10988147 |
RGD:11062092 |
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
|
IEP |
protein:increased expression:hyperplastic lung epithelium, alveolus (human) |
RGD |
PMID:20718723 |
RGD:6893300 |
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
|
|
G |
LOC110806263 |
TERT 5' regulatory region |
|
IAGP |
ClinVar Annotator: match by term: idiopathic fibrosing alveolitis |
ClinVar |
PMID:24033266 PMID:25741868 PMID:28492532 PMID:31268371 |
|
NCBI chr 5:1,294,628...1,298,988
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
|
IMP |
|
RGD |
PMID:21444868 |
RGD:7245946 |
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
|
|
G |
SCGB1A1 |
secretoglobin family 1A member 1 |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:15467329 |
RGD:5144148 |
NCBI chr11:62,419,033...62,423,195
Ensembl chr11:62,405,103...62,423,195
|
|
G |
TERT |
telomerase reverse transcriptase |
|
IAGP |
ClinVar Annotator: match by term: idiopathic fibrosing alveolitis |
ClinVar |
PMID:9536098 PMID:15814878 PMID:15885610 PMID:16247010 PMID:17460043 PMID:17576681 PMID:18042801 PMID:18460650 PMID:18635888 PMID:18931339 PMID:19561322 PMID:19674077 PMID:19760749 PMID:20301779 PMID:20502709 PMID:21436073 PMID:21520174 PMID:21602826 PMID:22853774 PMID:23538340 PMID:23716176 PMID:23901009 PMID:24033266 PMID:24763404 PMID:24833766 PMID:24983628 PMID:25365545 PMID:25741868 PMID:25785092 PMID:26024875 PMID:26136524 PMID:26580448 PMID:26859482 PMID:27192671 PMID:27418648 PMID:27540018 PMID:27848944 PMID:28104920 PMID:28492532 PMID:29036293 PMID:29483670 PMID:30426156 PMID:30523342 PMID:30791107 PMID:31268371 PMID:33709208 PMID:33850299 PMID:34019641 PMID:34482403 PMID:34565437 PMID:34890115 PMID:35776903 PMID:36622818 More...
|
|
NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
|
|
|
G |
ATM |
ATM serine/threonine kinase |
exacerbates |
ISO |
|
RGD |
PMID:31509427 |
RGD:126779564 |
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,804...108,369,102
|
|
G |
BTK |
Bruton tyrosine kinase |
ameliorates |
ISO |
Associated with Acute Lung Injury |
RGD |
PMID:29516781 |
RGD:124713566 |
NCBI chr X:101,349,450...101,390,796
Ensembl chr X:101,349,338...101,390,796
|
|
G |
DUOX1 |
dual oxidase 1 |
|
IEP |
protein:decreased expression:blood plasma (human) |
RGD |
PMID:24888898 |
RGD:40903071 |
NCBI chr15:45,129,994...45,165,574
Ensembl chr15:45,129,933...45,165,576
|
|
G |
DUOX2 |
dual oxidase 2 |
severity |
ISO |
|
RGD |
PMID:28936773 PMID:25751630 PMID:29556357 |
RGD:40924644, RGD:40925925, RGD:40925921 |
NCBI chr15:45,092,650...45,114,172
Ensembl chr15:45,092,650...45,114,172
|
|
G |
FAM157A |
family with sequence similarity 157 member A |
|
IEP |
protein:increased expression:blood plasma (human) |
RGD |
PMID:24888898 |
RGD:40903071 |
NCBI chr 3:198,153,206...198,222,513
Ensembl chr 3:198,180,755...198,190,365
|
|
G |
IFIH1 |
interferon induced with helicase C domain 1 |
|
ISO |
mRNA:increased expression:nasal cavity mucosa (mouse) |
RGD |
PMID:25751630 |
RGD:40925925 |
NCBI chr 2:162,267,074...162,318,684
Ensembl chr 2:162,267,074...162,318,684
|
|
G |
IL21 |
interleukin 21 |
|
ISO |
|
RGD |
PMID:25251568 |
RGD:127285548 |
NCBI chr 4:122,610,108...122,621,066
Ensembl chr 4:122,610,108...122,621,066
|
|
G |
IL27 |
interleukin 27 |
|
IEP |
protein:increased expression:blood serum (human) |
RGD |
PMID:22343630 |
RGD:126790513 |
NCBI chr16:28,499,362...28,506,834
Ensembl chr16:28,499,362...28,512,051
|
|
G |
IL32 |
interleukin 32 |
|
IEP |
protein:increased expression:blood serum (human) |
RGD |
PMID:22277801 PMID:19291698 PMID:18414668 |
RGD:150340718, RGD:150340751, RGD:150340729 |
NCBI chr16:3,065,403...3,069,530
Ensembl chr16:3,065,297...3,082,192
|
|
G |
KIR3DS1 |
killer cell immunoglobulin like receptor, three Ig domains and short cytoplasmic tail 1 |
exacerbates |
IAGP |
DNA:deletion: (human) |
RGD |
PMID:22652695 |
RGD:150340578 |
|
|
G |
MAP3K8 |
mitogen-activated protein kinase kinase kinase 8 |
exacerbates |
ISO |
|
RGD |
PMID:26241898 |
RGD:11055126 |
NCBI chr10:30,434,021...30,461,833
Ensembl chr10:30,434,021...30,461,833
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
ameliorates |
ISO |
|
RGD |
PMID:22514650 |
RGD:150340681 |
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MARCO |
macrophage receptor with collagenous structure |
ameliorates |
ISO |
|
RGD |
PMID:21562316 |
RGD:41412197 |
NCBI chr 2:118,942,194...118,994,660
Ensembl chr 2:118,942,194...118,994,660
|
|
G |
MAVS |
mitochondrial antiviral signaling protein |
disease_progression |
ISO |
|
RGD |
PMID:27438481 |
RGD:40903047 |
NCBI chr20:3,846,834...3,876,118
Ensembl chr20:3,846,799...3,876,123
|
|
G |
MIR146A |
microRNA 146a |
exacerbates ameliorates |
ISO |
|
RGD |
PMID:31638222 PMID:30611999 |
RGD:126925152, RGD:126925153 |
NCBI chr 5:160,485,352...160,485,450
Ensembl chr 5:160,485,352...160,485,450
|
|
G |
MX1 |
MX dynamin like GTPase 1 |
ameliorates |
ISO IMP |
fused with PTD 9-arginine sequence human gene in a mouse model |
RGD |
PMID:30696001 PMID:31653718 PMID:1371172 PMID:30945621 |
RGD:126777671, RGD:126777680, RGD:126777676, RGD:126777673 |
NCBI chr21:41,420,558...41,459,214
Ensembl chr21:41,420,020...41,470,071
|
|
G |
PLAC8 |
placenta associated 8 |
|
ISO |
|
RGD |
PMID:32639988 |
RGD:40925929 |
NCBI chr 4:83,090,048...83,114,729
Ensembl chr 4:83,059,493...83,137,075
|
|
G |
PPIA |
peptidylprolyl isomerase A |
ameliorates |
IMP |
human gene in a mouse model |
RGD |
PMID:27354005 |
RGD:150429624 |
NCBI chr 7:44,796,681...44,803,117
Ensembl chr 7:44,796,680...44,824,564
|
|
G |
RIGI |
RNA sensor RIG-I |
|
ISO |
mRNA:increased expression:nasal cavity mucosa (mouse) |
RGD |
PMID:25751630 |
RGD:40925925 |
NCBI chr 9:32,455,302...32,526,196
Ensembl chr 9:32,455,302...32,526,348
|
|
G |
RIPK3 |
receptor interacting serine/threonine kinase 3 |
exacerbates susceptibility |
ISO |
|
RGD |
PMID:27321907 PMID:32200799 PMID:28410401 |
RGD:127229911, RGD:127229922, RGD:127229918 |
NCBI chr14:24,336,025...24,339,991
Ensembl chr14:24,336,025...24,340,022
|
|
G |
SAA1 |
serum amyloid A1 |
|
IEP |
protein:increased expression:blood plasma (human) |
RGD |
PMID:24888898 |
RGD:40903071 |
NCBI chr11:18,266,264...18,269,967
Ensembl chr11:18,266,260...18,269,977
|
|
G |
STAT2 |
signal transducer and activator of transcription 2 |
exacerbates |
ISO |
|
RGD |
PMID:30337919 |
RGD:41789626 |
NCBI chr12:56,341,597...56,360,107
Ensembl chr12:56,341,597...56,360,203
|
|
|
G |
AGER |
advanced glycosylation end-product specific receptor |
|
ISO |
|
RGD |
PMID:21423669 |
RGD:5508765 |
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
severity |
ISO |
|
RGD |
PMID:11160230 |
RGD:11528533 |
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL20 |
C-C motif chemokine ligand 20 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:20926800 |
RGD:7483599 |
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
|
|
G |
CCR6 |
C-C motif chemokine receptor 6 |
disease_progression |
ISO |
|
RGD |
PMID:17379855 |
RGD:7483617 |
NCBI chr 6:167,111,795...167,139,141
Ensembl chr 6:167,111,807...167,139,141
|
|
G |
CXCR3 |
C-X-C motif chemokine receptor 3 |
|
IEP |
|
RGD |
PMID:17298426 |
RGD:5135501 |
NCBI chr X:71,615,919...71,618,511
Ensembl chr X:71,615,916...71,618,511
|
|
G |
CYBB |
cytochrome b-245 beta chain |
|
ISO |
|
RGD |
PMID:24054721 |
RGD:10450528 |
NCBI chr X:37,780,059...37,813,461
Ensembl chr X:37,780,018...37,813,461
|
|
G |
CYP2C19 |
cytochrome P450 family 2 subfamily C member 19 |
treatment |
IAGP |
DNA:polymorphisms:cds: |
RGD |
PMID:26861072 |
RGD:124713410 |
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
|
|
G |
ELANE |
elastase, neutrophil expressed |
|
ISO |
|
RGD |
PMID:24054721 |
RGD:10450528 |
NCBI chr19:852,303...856,243
Ensembl chr19:851,014...856,247
|
|
G |
IL17A |
interleukin 17A |
severity |
ISO |
|
RGD |
PMID:21807912 |
RGD:8698654 |
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
MBL2 |
mannose binding lectin 2 |
|
IAGP |
DNA:SNP:exon:rs5030737(human) |
RGD |
PMID:17311505 |
RGD:8693758 |
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
|
|
G |
PTX3 |
pentraxin 3 |
severity |
IAGP IEP |
DNA:SNPs, missense mutation:intron, cds:rs2305619, rs1840680, rs3816527 protein:increased expression:bronchoalveolar lavage fluid (human) |
RGD |
PMID:30275011 PMID:28487045 |
RGD:38501097, RGD:38508892 |
NCBI chr 3:157,436,850...157,443,633
Ensembl chr 3:157,436,850...157,443,633
|
|
G |
S100B |
S100 calcium binding protein B |
|
ISO |
|
RGD |
PMID:21423669 |
RGD:5508765 |
NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:16113258 |
RGD:8553022 |
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
|
|
G |
TLR4 |
toll like receptor 4 |
susceptibility |
IAGP |
DNA:polymorphism:exon:p.D299G(human) |
RGD |
PMID:18275280 |
RGD:5130863 |
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
treatment |
ISO |
|
RGD |
PMID:12917249 |
RGD:11528529 |
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CD209 |
CD209 molecule |
susceptibility |
IAGP |
DNA:SNPs:3'utr,intron:multiple |
RGD |
PMID:22384201 |
RGD:39938996 |
NCBI chr19:7,739,993...7,747,534
Ensembl chr19:7,739,993...7,747,564
|
|
G |
FGF2 |
fibroblast growth factor 2 |
treatment |
IDA |
|
RGD |
PMID:23303813 |
RGD:8655596 |
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
|
|
G |
IL1A |
interleukin 1 alpha |
|
IAGP |
DNA:polymorphism, haplotype:promoter:-889C>T (human) |
RGD |
PMID:18484169 |
RGD:4142867 |
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
|
IAGP |
DNA:polymorphism, haplotype: :-511C>T (human) |
RGD |
PMID:18484169 |
RGD:4142867 |
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
ITIH4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion, serum |
RGD |
PMID:24360996 |
RGD:40903005 |
NCBI chr 3:52,812,962...52,830,672
Ensembl chr 3:52,812,962...52,830,688
|
|
G |
MBL2 |
mannose binding lectin 2 |
treatment |
IDA |
|
RGD |
PMID:17335555 |
RGD:8693746 |
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
|
|
G |
PTX3 |
pentraxin 3 |
susceptibility no_association |
IAGP IEP |
DNA:SNP:intron:rs1840680 (human) protein:increased expression:bronchoalveolar lavage fluid, plasma (human) protein:increased expression:plasma DNA:SNP, missense mutation:intron, cds:rs2305619, rs3816527 |
RGD |
PMID:29020397 PMID:29964232 PMID:29020397 PMID:29020397 |
RGD:38501098, RGD:38508894, RGD:38501098, RGD:38501098 |
NCBI chr 3:157,436,850...157,443,633
Ensembl chr 3:157,436,850...157,443,633
|
|
G |
VEGFA |
vascular endothelial growth factor A |
treatment |
IDA |
|
RGD |
PMID:23303813 |
RGD:8655596 |
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
|
RGD |
PMID:11207292 |
RGD:38549344 |
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
IL23A |
interleukin 23 subunit alpha |
severity |
ISO |
|
RGD |
PMID:16157683 |
RGD:39457940 |
NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410
|
|
G |
IRAK3 |
interleukin 1 receptor associated kinase 3 |
severity |
ISO |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:22729155 PMID:20864681 |
RGD:35316077, RGD:36049798 |
NCBI chr12:66,189,214...66,254,622
Ensembl chr12:66,189,195...66,254,622
|
|
G |
LCN2 |
lipocalin 2 |
exacerbates ameliorates |
ISO |
protein:increased expression:lung protein:increased expression:serum |
RGD |
PMID:29633303 PMID:19342674 PMID:19342674 PMID:19342674 PMID:25234944 PMID:25234944 More...
|
RGD:126725082, RGD:126725085, RGD:126725085, RGD:126725085, RGD:126725084, RGD:126725084 |
NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
|
|
G |
PLAC8 |
placenta associated 8 |
severity |
ISO |
|
RGD |
PMID:17404296 |
RGD:40924563 |
NCBI chr 4:83,090,048...83,114,729
Ensembl chr 4:83,059,493...83,137,075
|
|
G |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
disease_progression |
ISO |
|
RGD |
PMID:24396044 |
RGD:126925976 |
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,100...41,286,682
|
|
|
G |
ADA |
adenosine deaminase |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:9255891 |
RGD:5128857 |
NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252
|
|
G |
CX3CL1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:16113250 |
RGD:4891897 |
NCBI chr16:57,372,490...57,385,044
Ensembl chr16:57,372,477...57,385,044
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CXCL5 |
C-X-C motif chemokine ligand 5 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
|
|
G |
CXCL6 |
C-X-C motif chemokine ligand 6 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr 4:73,836,678...73,838,760
Ensembl chr 4:73,836,640...73,849,064
|
|
G |
CXCR2 |
C-X-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr 2:218,125,294...218,137,251
Ensembl chr 2:218,125,289...218,137,251
|
|
G |
IFNG |
interferon gamma |
|
EXP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11349020 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:11083766 |
RGD:4889865 |
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096
|
|
G |
MBL2 |
mannose binding lectin 2 |
susceptibility |
IEP |
|
RGD |
PMID:19073229 |
RGD:12910934 |
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
|
|
G |
NOD1 |
nucleotide binding oligomerization domain containing 1 |
|
ISO |
|
RGD |
PMID:20685341 |
RGD:5131443 |
NCBI chr 7:30,424,527...30,478,784
Ensembl chr 7:30,424,527...30,478,784
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
|
ISO |
|
RGD |
PMID:20685341 |
RGD:5131443 |
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
|
|
G |
TLR5 |
toll like receptor 5 |
susceptibility |
IAGP EXP ISO |
DNA:nonsense mutation:cds:p.R392X (human) ClinVar Annotator: match by term: Legionnaire disease, susceptibility to CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD RGD |
PMID:14623910 PMID:16027372 PMID:23447684 PMID:14623910 PMID:17982089 |
RGD:5129477, RGD:5129510 |
NCBI chr 1:223,109,404...223,143,248
Ensembl chr 1:223,109,404...223,143,292
|
|
G |
TLR9 |
toll like receptor 9 |
|
ISO |
|
RGD |
PMID:18426877 |
RGD:5130707 |
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
|
ISO |
|
RGD |
PMID:18838275 |
RGD:5131445 |
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
|
|
G |
TNFRSF1B |
TNF receptor superfamily member 1B |
|
ISO |
|
RGD |
PMID:18838275 |
RGD:5131445 |
NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228
|
|
|
G |
ADA |
adenosine deaminase |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:9255891 |
RGD:5128857 |
NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252
|
|
G |
ATP1B2 |
ATPase Na+/K+ transporting subunit beta 2 |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr17:7,646,627...7,657,770
Ensembl chr17:7,646,627...7,657,770
|
|
G |
CCL4 |
C-C motif chemokine ligand 4 |
|
ISO |
|
RGD |
PMID:16988274 |
RGD:4892091 |
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased secretion:lung, secretion (mouse) |
RGD |
PMID:18717637 |
RGD:4891914 |
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CCL8 |
C-C motif chemokine ligand 8 |
|
ISO |
|
RGD |
PMID:16988274 |
RGD:4892091 |
NCBI chr17:34,319,435...34,321,402
Ensembl chr17:34,319,435...34,321,402
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
ISO |
protein:increased expression:lung, T-helper cell (mouse) |
RGD |
PMID:16988274 |
RGD:4892091 |
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
|
|
G |
CLEC5A |
C-type lectin domain containing 5A |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 7:141,927,357...141,946,974
Ensembl chr 7:141,927,357...141,947,007
|
|
G |
COL3A1 |
collagen type III alpha 1 chain |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
|
|
G |
COL6A1 |
collagen type VI alpha 1 chain |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr21:45,981,770...46,005,048
Ensembl chr21:45,981,770...46,005,050
|
|
G |
COL6A2 |
collagen type VI alpha 2 chain |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr21:46,098,112...46,132,848
Ensembl chr21:46,098,112...46,132,848
|
|
G |
CRP |
C-reactive protein |
|
IEP |
|
RGD |
PMID:21426633 |
RGD:5131292 |
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
|
|
G |
DNASE1L3 |
deoxyribonuclease 1L3 |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 3:58,192,257...58,210,972
Ensembl chr 3:58,192,257...58,214,697
|
|
G |
FCER2 |
Fc epsilon receptor II |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr19:7,688,776...7,702,131
Ensembl chr19:7,688,758...7,702,146
|
|
G |
FLT1 |
fms related receptor tyrosine kinase 1 |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
|
|
G |
GALC |
galactosylceramidase |
|
IEP ISO |
associated with Guillain-Barre syndrome; protein:increased expression:serum (human) associated with Guillain-Barre syndrome; protein:increased expression:Cerebrospinal fluid, serum (human) protein:increased expression:serum (mouse) |
RGD |
PMID:27490360 PMID:29301655 PMID:30396892 PMID:30396892 PMID:12225900 |
RGD:38599168, RGD:38599172, RGD:38599171, RGD:38599171, RGD:38599169 |
NCBI chr14:87,933,014...87,993,667
Ensembl chr14:87,837,820...87,993,665
|
|
G |
HDC |
histidine decarboxylase |
|
ISO |
|
RGD |
PMID:17158962 |
RGD:5143920 |
NCBI chr15:50,241,947...50,265,726
Ensembl chr15:50,241,947...50,265,965
|
|
G |
HTRA3 |
HtrA serine peptidase 3 |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 4:8,269,754...8,307,098
Ensembl chr 4:8,269,754...8,307,098
|
|
G |
IFNG |
interferon gamma |
|
ISO |
mRNA:increased expression:lung: |
RGD |
PMID:7935058 |
RGD:10755754 |
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL13 |
interleukin 13 |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:20416219 |
RGD:4145765 |
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
|
|
G |
IL22RA2 |
interleukin 22 receptor subunit alpha 2 |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 6:137,143,820...137,173,644
Ensembl chr 6:137,143,820...137,173,648
|
|
G |
INHBA |
inhibin subunit beta A |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 7:41,685,114...41,705,406
Ensembl chr 7:41,667,168...41,705,834
|
|
G |
KLRF1 |
killer cell lectin like receptor F1 |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr12:9,800,052...9,845,005
Ensembl chr12:9,827,481...9,845,007
|
|
G |
MS4A1 |
membrane spanning 4-domains A1 |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr11:60,455,847...60,470,752
Ensembl chr11:60,455,846...60,470,752
|
|
G |
PLD4 |
phospholipase D family member 4 |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr14:104,924,879...104,937,785
Ensembl chr14:104,924,713...104,937,761
|
|
G |
SPIB |
Spi-B transcription factor |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr19:50,418,938...50,431,314
Ensembl chr19:50,418,938...50,431,314
|
|
G |
TCF7 |
transcription factor 7 |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 5:134,108,218...134,148,210
Ensembl chr 5:134,114,681...134,151,865
|
|
G |
TCL1A |
TCL1 family AKT coactivator A |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr14:95,709,947...95,714,125
Ensembl chr14:95,709,947...95,714,196
|
|
G |
TNF |
tumor necrosis factor |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:20416219 |
RGD:4145765 |
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF13C |
TNF receptor superfamily member 13C |
severity |
HEP |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr22:41,922,032...41,926,806
Ensembl chr22:41,922,032...41,926,806
|
|
|
G |
PTCH1 |
patched 1 |
|
IEP |
mRNA:decreased expression:epithelium of nasopharynx |
RGD |
PMID:23001130 |
RGD:150523839 |
NCBI chr 9:95,442,980...95,516,971
Ensembl chr 9:95,442,980...95,517,057
|
|
|
G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
|
IEP |
protein:decreased expression:serum |
RGD |
PMID:19725899 |
RGD:5686851 |
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
|
|
G |
ALB |
albumin |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19389874 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
ALOX5AP |
arachidonate 5-lipoxygenase activating protein |
|
IEP |
protein:increased expression:nasal turbinate |
RGD |
PMID:19364335 |
RGD:5147461 |
NCBI chr13:30,713,485...30,764,426
Ensembl chr13:30,713,478...30,764,426
|
|
G |
CAT |
catalase |
|
IEP |
protein:decreased expression:plasma |
RGD |
PMID:20493834 |
RGD:5130771 |
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
IEP |
protein:increased expression:nasal turbinate, mucosa (human) |
RGD |
PMID:9865755 |
RGD:8548839 |
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
IEP |
mRNA:increased expression:Nasal Mucosa |
RGD |
PMID:17982926 |
RGD:4145109 |
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
IEP |
mRNA:increased expression:nasal mucosa (human) |
RGD |
PMID:17982926 |
RGD:4145109 |
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
|
|
G |
CD40 |
CD40 molecule |
|
ISO |
|
RGD |
PMID:20226305 |
RGD:5132269 |
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
|
|
G |
CD86 |
CD86 molecule |
|
IEP |
protein:increased expression:nasal mucosa, dendritic cell (human) |
RGD |
PMID:17088138 |
RGD:4892343 |
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
|
|
G |
CHIA |
chitinase acidic |
|
IEP |
mRNA, protein:increased expression:turbinate, mucosa (human) |
RGD |
PMID:20422678 |
RGD:5037226 |
NCBI chr 1:111,290,851...111,320,563
Ensembl chr 1:111,290,851...111,320,566
|
|
G |
EGR1 |
early growth response 1 |
|
IAGP |
DNA:snp:5' utr:g.-4071A>G rs7729723 (human) |
RGD |
PMID:19833116 |
RGD:5131984 |
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
G |
F2RL1 |
F2R like trypsin receptor 1 |
|
IEP |
|
RGD |
PMID:17727088 |
RGD:4892590 |
NCBI chr 5:76,819,030...76,835,315
Ensembl chr 5:76,818,933...76,835,315
|
|
G |
GSTP1 |
glutathione S-transferase pi 1 |
susceptibility |
IAGP |
DNA:polymorphism:exon:p.I105V (rs1695) (human) |
RGD |
PMID:17181111 |
RGD:4142523 |
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
|
|
G |
HMOX1 |
heme oxygenase 1 |
|
IEP |
mRNA, protein:increased expression: nasal mucosa |
RGD |
PMID:16540907 |
RGD:4145406 |
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
ISO IEP |
protein:increased expression:lung, endothelium (mouse) protein:increased secretion:nasopharynx (human) |
RGD |
PMID:19968652 PMID:19047814 |
RGD:4145464, RGD:4145520 |
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IFNGR1 |
interferon gamma receptor 1 |
|
IAGP |
DNA: SNP: Leu467Pro |
RGD |
PMID:12851715 |
RGD:6480431 |
NCBI chr 6:137,197,484...137,219,385
Ensembl chr 6:137,197,483...137,219,449
|
|
G |
IL13 |
interleukin 13 |
|
IEP |
mRNA, protein:increased expression:nasal mucosa |
RGD |
PMID:8520776 |
RGD:4782826 |
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
|
|
G |
IL17A |
interleukin 17A |
severity |
IEP |
protein:increased expression:serum |
RGD |
PMID:19226302 |
RGD:4889151 |
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL18 |
interleukin 18 |
susceptibility |
IAGP |
DNA:SNP:promoter:c. -607A>C (rs1946518) (human) |
RGD |
PMID:16406079 |
RGD:4889924 |
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096
|
|
G |
IL1A |
interleukin 1 alpha |
|
IAGP |
DNA:polymorphism:exon:c.4845G>T (human) |
RGD |
PMID:14533660 |
RGD:4142859 |
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1R1 |
interleukin 1 receptor type 1 |
|
IDA |
|
RGD |
PMID:18637763 |
RGD:5037238 |
NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874
|
|
G |
IL2 |
interleukin 2 |
|
IEP |
protein:decreased expression:serum: |
RGD |
PMID:17608155 |
RGD:8662959 |
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
|
|
G |
IL4 |
interleukin 4 |
treatment |
IEP |
protein:increased expression:serum |
RGD |
PMID:21171297 PMID:9237816 PMID:15329007 |
RGD:5128559, RGD:7829817, RGD:7829804 |
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL5 |
interleukin 5 |
|
IEP |
protein: increased levels: sputum |
RGD |
PMID:22186238 |
RGD:5687140 |
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
|
IEP |
protein:increased expression:nasal mucosa: |
RGD |
PMID:19786210 |
RGD:5130872 |
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
IEP |
protein:increased expression:nasal mucosa: |
RGD |
PMID:19786210 |
RGD:5130872 |
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:nasal mucosa |
RGD |
PMID:14587983 |
RGD:4892078 |
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
|
IAGP |
DNA:snp:promoter:g.-786T>C (human) |
RGD |
PMID:18086269 |
RGD:4892054 |
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
|
IEP |
protein:altered expression:nasal mucosa |
RGD |
PMID:20185258 |
RGD:4892593 |
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
|
IEP |
mRNA, protein:increased expression:nasal mucosa (human) |
RGD |
PMID:17116814 |
RGD:8552811 |
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
|
IEP |
protein:increased expression:respiratory system epithelium |
RGD |
PMID:19364335 |
RGD:5147461 |
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
|
|
G |
TBXA2R |
thromboxane A2 receptor |
treatment |
IMP |
|
RGD |
PMID:15247523 |
RGD:11059532 |
NCBI chr19:3,594,507...3,606,875
Ensembl chr19:3,594,507...3,606,875
|
|
|
G |
PLAU |
plasminogen activator, urokinase |
|
IDA |
Gene product used in treatment of disease |
RGD |
PMID:20304453 |
RGD:4891955 |
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
|
|
G |
TNC |
tenascin C |
|
IEP |
protein:increased expression:pleura |
RGD |
PMID:10950882 |
RGD:4889594 |
NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
|
|
G |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
treatment |
ISO |
|
RGD |
PMID:20819512 |
RGD:127284851 |
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,100...41,286,682
|
|
|
G |
ADA |
adenosine deaminase |
|
IEP IDA |
protein:increased activity:pleural fluid: protein:increased activity:serum: protein:increased expression:serum: |
RGD |
PMID:21860532 PMID:1818842 PMID:1689629 PMID:18357489 |
RGD:152995280, RGD:152998934, RGD:152995292, RGD:152995288 |
NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252
|
|
G |
ADA2 |
adenosine deaminase 2 |
treatment |
IEP |
|
RGD |
PMID:8656037 |
RGD:152995258 |
NCBI chr22:17,178,790...17,221,848
Ensembl chr22:17,178,790...17,258,235
|
|
G |
CCL22 |
C-C motif chemokine ligand 22 |
|
IEP |
|
RGD |
PMID:20337996 |
RGD:4891473 |
NCBI chr16:57,357,909...57,366,189
Ensembl chr16:57,358,783...57,366,189
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
IDA |
|
RGD |
PMID:19159432 |
RGD:4145106 |
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
IEP |
protein:increased expression:pleural fluid, natural killer cell (human) |
RGD |
PMID:19159432 |
RGD:4145106 |
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
|
|
G |
FOXP3 |
forkhead box P3 |
disease_progression |
IEP |
associated with human immunodeficiency virus infectious disease; |
RGD |
PMID:21303360 |
RGD:36947878 |
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800
|
|
G |
IL1B |
interleukin 1 beta |
|
IAGP |
DNA:polymorphism: :3953T>C (human) |
RGD |
PMID:10377182 |
RGD:4143226 |
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
IAGP |
DNA:repeat (human) |
RGD |
PMID:10377182 |
RGD:4143226 |
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
|
|
G |
IL27 |
interleukin 27 |
exacerbates |
IEP |
associated with Pleural Effusion;protein:increased expression:pleural fluid (human) protein:increased expression:alveolar system (human) |
RGD |
PMID:25753767 PMID:31819557 PMID:23962500 PMID:28844060 |
RGD:126790505, RGD:126790549, RGD:126790523, RGD:126790517 |
NCBI chr16:28,499,362...28,506,834
Ensembl chr16:28,499,362...28,512,051
|
|
G |
IL33 |
interleukin 33 |
|
IEP |
protein:increased expression:pleural fluid: |
RGD |
PMID:23301222 |
RGD:39939042 |
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
|
IEP |
protein:increased expression:pleura: |
RGD |
PMID:18715875 |
RGD:5129700 |
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
TLR4 |
toll like receptor 4 |
|
IEP |
|
RGD |
PMID:18295348 |
RGD:4144193 |
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TNC |
tenascin C |
|
IEP |
protein:increased expression:pleura |
RGD |
PMID:10950882 |
RGD:4889594 |
NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
|
|
|
G |
ADA |
adenosine deaminase |
|
ISO |
|
RGD |
PMID:16860713 |
RGD:5128847 |
NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:9109363 |
RGD:4890429 |
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
|
|
G |
ANXA1 |
annexin A1 |
|
ISO |
|
RGD |
PMID:15784654 |
RGD:2306907 |
NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,629
|
|
G |
BDKRB1 |
bradykinin receptor B1 |
|
ISO |
|
RGD |
PMID:11853231 |
RGD:5129218 |
NCBI chr14:96,256,210...96,264,763
Ensembl chr14:96,256,210...96,268,967
|
|
G |
BDKRB2 |
bradykinin receptor B2 |
|
ISO |
|
RGD |
PMID:15316088 PMID:9208140 |
RGD:4891029, RGD:4891041 |
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
|
|
G |
C3 |
complement C3 |
|
ISO |
protein:increased activity:pleural cavity |
RGD |
PMID:18256172 |
RGD:5129520 |
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
|
|
G |
CAT |
catalase |
|
ISO |
|
RGD |
PMID:19778612 |
RGD:5130749 |
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL11 |
C-C motif chemokine ligand 11 |
|
ISO |
protein:increased expression:pleural fluid |
RGD |
PMID:11877329 PMID:11564646 |
RGD:4145443, RGD:4145479 |
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
|
|
G |
CCL25 |
C-C motif chemokine ligand 25 |
|
ISO |
protein:increased expression:pleural fluid |
RGD |
PMID:18056919 |
RGD:5130924 |
NCBI chr19:8,052,341...8,062,650
Ensembl chr19:8,052,318...8,062,660
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased secretion:lung (mouse) |
RGD |
PMID:18672096 |
RGD:4890016 |
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CCR3 |
C-C motif chemokine receptor 3 |
|
ISO |
associated with Mycobacterium Infections |
RGD |
PMID:17158890 |
RGD:4145643 |
NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
|
|
G |
CSF3 |
colony stimulating factor 3 |
|
IDA |
|
RGD |
PMID:8841835 |
RGD:11039424 |
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:14527170 |
RGD:5135449 |
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
|
RGD |
PMID:14527170 |
RGD:5135449 |
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
|
ISO |
|
RGD |
PMID:21549112 PMID:14527170 |
RGD:5135064, RGD:5135449 |
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
|
RGD |
PMID:14527170 |
RGD:5135449 |
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
|
|
G |
EDNRA |
endothelin receptor type A |
|
ISO |
|
RGD |
PMID:15107459 |
RGD:4892325 |
NCBI chr 4:147,481,097...147,544,954
Ensembl chr 4:147,480,917...147,544,954
|
|
G |
ELANE |
elastase, neutrophil expressed |
|
ISO |
|
RGD |
PMID:20860667 |
RGD:10450565 |
NCBI chr19:852,303...856,243
Ensembl chr19:851,014...856,247
|
|
G |
ESR1 |
estrogen receptor 1 |
|
ISO |
|
RGD |
PMID:17035596 |
RGD:4892303 |
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
|
IEP EXP ISO |
associated with Tuberculosis; protein:increased expression:pleural fluid, natural killer cell (human) CTD Direct Evidence: marker/mechanism protein:increased expression:bronchial epithelium (mouse) |
CTD RGD |
PMID:11181422 PMID:19714575 PMID:19056932 |
RGD:4145510, RGD:4145519 |
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IL10 |
interleukin 10 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11181422 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL15 |
interleukin 15 |
|
IDA |
|
RGD |
PMID:10823416 |
RGD:4990464 |
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
|
|
G |
IL17A |
interleukin 17A |
treatment |
ISO |
|
RGD |
PMID:21898269 |
RGD:7175307 |
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL1B |
interleukin 1 beta |
|
ISO EXP |
CTD Direct Evidence: marker/mechanism protein:increased expression:pleural cavity, exudate (rat) protein:increased expression:lung |
CTD RGD |
PMID:11181422 PMID:20141620 PMID:21898269 PMID:20175894 |
RGD:4142808, RGD:7175307, RGD:4142826 |
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
|
IDA |
|
RGD |
PMID:8491511 |
RGD:4143233 |
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
|
|
G |
IL6 |
interleukin 6 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11181422 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
MPO |
myeloperoxidase |
|
ISO |
protein:increased activity:lung |
RGD |
PMID:11577999 |
RGD:5130991 |
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
|
RGD |
PMID:14673141 |
RGD:6893408 |
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:pleural cavity (rat) |
RGD |
PMID:21898269 PMID:20141620 |
RGD:7175307, RGD:4142808 |
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
PLA2G6 |
phospholipase A2 group VI |
|
ISO |
|
RGD |
PMID:15003994 |
RGD:6482741 |
NCBI chr22:38,111,495...38,181,830
Ensembl chr22:38,111,495...38,214,778
|
|
G |
PTAFR |
platelet activating factor receptor |
treatment |
ISO |
|
RGD |
PMID:8395390 |
RGD:10043147 |
NCBI chr 1:28,147,166...28,193,856
Ensembl chr 1:28,147,166...28,193,936
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
|
RGD |
PMID:20141620 PMID:15740981 |
RGD:4142808, RGD:5143929 |
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
SELP |
selectin P |
|
ISO EXP |
protein:increased expression:lung CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11181422 PMID:21147071 |
RGD:6219005 |
NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193
|
|
G |
SERPINE1 |
serpin family E member 1 |
susceptibility |
IAGP |
associated with Familial Mediterranean Fever;DNA: DNA:polymorphism:promoter:rs1799768 (human): |
RGD |
PMID:23052617 |
RGD:13207414 |
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
|
|
G |
TNF |
tumor necrosis factor |
|
ISO EXP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11181422 PMID:11161459 PMID:20141620 |
RGD:4143474, RGD:4142808 |
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:12773506 |
RGD:4890419 |
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
|
|
|
G |
AICDA |
activation induced cytidine deaminase |
|
ISO |
|
RGD |
PMID:26456931 |
RGD:11098923 |
NCBI chr12:8,602,170...8,612,859
Ensembl chr12:8,602,155...8,613,242
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:20231413 |
RGD:4890435 |
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
|
|
G |
BTK |
Bruton tyrosine kinase |
ameliorates |
ISO |
|
RGD |
PMID:30646846 |
RGD:124715470 |
NCBI chr X:101,349,450...101,390,796
Ensembl chr X:101,349,338...101,390,796
|
|
G |
C3 |
complement C3 |
disease_progression |
ISO IEP |
associated with Liver Cirrhosis, Experimental;protein:decreased expression:respiratory system fluid/secretion protein:decreased expression:serum |
RGD |
PMID:17956621 PMID:15972516 PMID:20405 |
RGD:5129523, RGD:5129509, RGD:5130163 |
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
|
|
G |
C5 |
complement C5 |
severity |
ISO |
|
RGD |
PMID:7814608 |
RGD:5130159 |
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
susceptibility |
ISO |
|
RGD |
PMID:16455992 |
RGD:4892130 |
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CD14 |
CD14 molecule |
|
ISO |
|
RGD |
PMID:17185649 |
RGD:4144788 |
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
|
|
G |
CHI3L1 |
chitinase 3 like 1 |
|
IEP |
protein:increased secretion:serum (human) |
RGD |
PMID:10515841 |
RGD:4892626 |
NCBI chr 1:203,178,931...203,186,704
Ensembl chr 1:203,178,931...203,186,704
|
|
G |
CRHR1 |
corticotropin releasing hormone receptor 1 |
|
ISO |
|
RGD |
PMID:21774994 |
RGD:5147472 |
NCBI chr17:45,784,320...45,835,828
Ensembl chr17:45,784,277...45,835,828
|
|
G |
CRHR2 |
corticotropin releasing hormone receptor 2 |
|
ISO |
|
RGD |
PMID:21774994 |
RGD:5147472 |
NCBI chr 7:30,651,942...30,700,103
Ensembl chr 7:30,651,942...30,700,129
|
|
G |
CRP |
C-reactive protein |
disease_progression |
IEP |
|
RGD |
PMID:21281676 |
RGD:5131293 |
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:20958976 |
RGD:5134957 |
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:20381636 |
RGD:5135285 |
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
|
|
G |
DEFB4A |
defensin beta 4A |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr 8:7,894,677...7,896,716
Ensembl chr 8:7,894,677...7,896,716 Ensembl chr 8:7,894,677...7,896,716
|
|
G |
HMOX1 |
heme oxygenase 1 |
|
ISO |
associated with influenza;protein:increased expression:lung |
RGD |
PMID:17348295 |
RGD:4145366 |
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HP |
haptoglobin |
|
IEP |
|
RGD |
PMID:19396720 |
RGD:5147385 |
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
|
|
G |
IL15 |
interleukin 15 |
|
ISO |
protein:increased expression:alveolar macrophage, bronchial epithelial cell |
RGD |
PMID:17611121 |
RGD:5000755 |
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
|
|
G |
IL15RA |
interleukin 15 receptor subunit alpha |
|
ISO |
|
RGD |
PMID:17611121 |
RGD:5000755 |
NCBI chr10:5,948,900...5,978,741
Ensembl chr10:5,943,639...5,978,187
|
|
G |
IL17A |
interleukin 17A |
|
ISO |
|
RGD |
PMID:19995896 |
RGD:4888531 |
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:15770015 |
RGD:4889960 |
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096
|
|
G |
IL6 |
interleukin 6 |
|
ISO |
|
RGD |
PMID:20643849 |
RGD:4143255 |
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
LEP |
leptin |
|
ISO |
|
RGD |
PMID:17822444 |
RGD:5128869 |
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
|
|
G |
LEPR |
leptin receptor |
|
ISO |
|
RGD |
PMID:21148797 |
RGD:5128846 |
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MASP2 |
MBL associated serine protease 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12904520 |
|
NCBI chr 1:11,026,523...11,047,239
Ensembl chr 1:11,022,009...11,047,239
|
|
G |
MBL2 |
mannose binding lectin 2 |
no_association |
IAGP |
DNA:polymorphisms:5' utr, exon:multiple (human) DNA:mutations:5' utr, exon:multiple (human) |
RGD |
PMID:12047967 PMID:18641104 |
RGD:4889478, RGD:4889477 |
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
|
RGD |
PMID:17056580 |
RGD:4891950 |
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
PTEN |
phosphatase and tensin homolog |
ameliorates |
ISO |
myeloid knockout |
RGD |
PMID:20505137 |
RGD:127285597 |
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
|
|
G |
SFTPD |
surfactant protein D |
severity |
ISO |
|
RGD |
PMID:16255775 |
RGD:4143519 |
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
|
|
G |
SIRT1 |
sirtuin 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
|
|
G |
STING1 |
stimulator of interferon response cGAMP interactor 1 |
|
ISO |
|
RGD |
PMID:29263110 |
RGD:39128230 |
NCBI chr 5:139,475,533...139,482,758
Ensembl chr 5:139,475,533...139,482,935
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:19956717 |
RGD:4145321 |
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
|
|
G |
TNF |
tumor necrosis factor |
|
ISO |
associated with influenza;protein:increased expression:lung |
RGD |
PMID:9032201 PMID:17348295 |
RGD:4143479, RGD:4145366 |
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TREM1 |
triggering receptor expressed on myeloid cells 1 |
ameliorates |
ISO |
|
RGD |
PMID:24752755 PMID:19596984 |
RGD:126928121, RGD:127229903 |
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,100...41,286,682
|
|
|
G |
AZIN1 |
antizyme inhibitor 1 |
|
ISO |
mRNA:increased expression:alveolar macrophage |
RGD |
PMID:19158080 |
RGD:14700806 |
NCBI chr 8:102,826,302...102,864,200
Ensembl chr 8:102,826,111...102,893,864
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:17169032 |
RGD:5129525 |
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
IEP |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:20618689 |
RGD:4891428 |
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CD40 |
CD40 molecule |
treatment |
ISO |
|
RGD |
PMID:10968950 |
RGD:8547797 |
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
|
|
G |
CSF2 |
colony stimulating factor 2 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:19487471 |
RGD:5131475 |
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
HLA-DQB1 |
major histocompatibility complex, class II, DQ beta 1 |
|
ISO |
|
RGD |
PMID:20377877 |
RGD:4144112 |
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
|
|
G |
IL23A |
interleukin 23 subunit alpha |
|
ISO |
|
RGD |
PMID:17403873 |
RGD:39458043 |
NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410
|
|
G |
IL33 |
interleukin 33 |
treatment |
ISO |
|
RGD |
PMID:21220696 |
RGD:40400892 |
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
|
|
G |
MUC1 |
mucin 1, cell surface associated |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:9617869 |
RGD:5131424 |
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
|
|
G |
NOS2 |
nitric oxide synthase 2 |
|
ISO |
protein:decreased dimerization:alveolar macrophage mRNA:increased expression:alveolar macrophage |
RGD |
PMID:20558778 PMID:20377877 |
RGD:4891486, RGD:4144112 |
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
SFTPA1 |
surfactant protein A1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr10:79,610,939...79,615,455
Ensembl chr10:79,610,939...79,615,455
|
|
G |
SFTPB |
surfactant protein B |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr 2:85,657,307...85,668,741
Ensembl chr 2:85,657,314...85,668,741
|
|
G |
SFTPC |
surfactant protein C |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr 8:22,157,383...22,164,479
Ensembl chr 8:22,156,913...22,164,479
|
|
G |
SFTPD |
surfactant protein D |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr10:79,937,740...79,982,383
Ensembl chr10:79,937,467...79,982,614
|
|
G |
TLR2 |
toll like receptor 2 |
|
ISO |
|
RGD |
PMID:18400546 |
RGD:4145341 |
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
|
|
|
G |
ABCF1 |
ATP binding cassette subfamily F member 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 6:30,571,442...30,591,522
Ensembl chr 6:30,571,393...30,597,179
|
|
G |
ABO |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
severity |
IAGP |
DNA:polymorphism:cds:allele A (human) |
RGD |
PMID:4375858 |
RGD:39938844 |
NCBI chr 9:133,250,401...133,275,201
Ensembl chr 9:133,233,278...133,276,024
|
|
G |
ACE |
angiotensin I converting enzyme |
disease_progression |
IEP IMP |
associated with Hypertension |
RGD |
PMID:17727310 PMID:20051911 PMID:19455553 |
RGD:4140922, RGD:4140916, RGD:4140918 |
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
|
|
G |
ADORA1 |
adenosine A1 receptor |
|
ISO |
|
RGD |
PMID:15630442 |
RGD:5129098 |
NCBI chr 1:203,127,726...203,167,405
Ensembl chr 1:203,090,654...203,167,405
|
|
G |
ADORA2A |
adenosine A2a receptor |
|
ISO |
associated with Lung Injury associated with Anemia, Sickle Cell |
RGD |
PMID:18703794 PMID:17601796 PMID:20798237 |
RGD:4890364, RGD:4890376, RGD:4890358 |
NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357
|
|
G |
ADRB2 |
adrenoceptor beta 2 |
|
ISO |
|
RGD |
PMID:19925785 |
RGD:4145041 |
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
|
|
G |
AGT |
angiotensinogen |
|
EXP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:28960804 |
|
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
|
|
G |
AHR |
aryl hydrocarbon receptor |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23337360 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
ALB |
albumin |
disease_progression |
IEP |
|
RGD |
PMID:23286966 |
RGD:11035283 |
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
BDKRB2 |
bradykinin receptor B2 |
|
ISO |
|
RGD |
PMID:15021973 |
RGD:4891030 |
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:10886251 |
RGD:5129562 |
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
|
|
G |
C3AR1 |
complement C3a receptor 1 |
|
ISO |
associated with Respiratory Syncytial Virus Infections |
RGD |
PMID:17079327 |
RGD:5129688 |
NCBI chr12:8,056,844...8,066,359
Ensembl chr12:8,056,844...8,066,359
|
|
G |
C5 |
complement C5 |
|
IDA ISO |
associated with Respiratory Syncytial Virus Infections |
RGD |
PMID:3631740 PMID:17079327 |
RGD:5130161, RGD:5129688 |
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
|
|
G |
CASP1 |
caspase 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CCL11 |
C-C motif chemokine ligand 11 |
|
ISO EXP |
mRNA, protein:increased expression:lung, respiratory system fluid/secretion CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21625544 PMID:11290805 PMID:10595930 |
RGD:4145445, RGD:4145450 |
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
|
|
G |
CCL13 |
C-C motif chemokine ligand 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr17:34,356,480...34,358,610
Ensembl chr17:34,356,480...34,358,610
|
|
G |
CCL17 |
C-C motif chemokine ligand 17 |
|
ISO EXP |
mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21625544 PMID:15993846 |
RGD:2306304 |
NCBI chr16:57,396,093...57,416,063
Ensembl chr16:57,404,767...57,416,063
|
|
G |
CCL19 |
C-C motif chemokine ligand 19 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 9:34,689,570...34,691,276
Ensembl chr 9:34,689,570...34,691,276
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
|
ISO EXP |
protein:increased expression:respiratory system fluid/secretion CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21625544 PMID:19648283 |
RGD:4891461 |
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL20 |
C-C motif chemokine ligand 20 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
|
|
G |
CCL22 |
C-C motif chemokine ligand 22 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:15993846 |
RGD:2306304 |
NCBI chr16:57,357,909...57,366,189
Ensembl chr16:57,358,783...57,366,189
|
|
G |
CCL23 |
C-C motif chemokine ligand 23 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr17:36,013,058...36,017,972
Ensembl chr17:36,013,056...36,017,972
|
|
G |
CCL24 |
C-C motif chemokine ligand 24 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 7:75,810,825...75,823,372
Ensembl chr 7:75,810,825...75,823,356
|
|
G |
CCL3 |
C-C motif chemokine ligand 3 |
|
HEP |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
|
|
G |
CCL4 |
C-C motif chemokine ligand 4 |
|
EXP HEP |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:bronchoalveolar lavage (human) |
CTD RGD |
PMID:21625544 PMID:32407669 |
RGD:30296672 |
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
|
IEP EXP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21625544 PMID:15191918 |
RGD:5130985 |
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
|
|
G |
CCL8 |
C-C motif chemokine ligand 8 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr17:34,319,435...34,321,402
Ensembl chr17:34,319,435...34,321,402
|
|
G |
CCR1 |
C-C motif chemokine receptor 1 |
|
ISO EXP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21625544 PMID:20870892 |
RGD:5688175 |
NCBI chr 3:46,201,711...46,208,313
Ensembl chr 3:46,201,711...46,208,313
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
|
ISO EXP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21625544 PMID:14615370 PMID:17284325 |
RGD:4145068, RGD:8661704 |
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
|
|
G |
CCR3 |
C-C motif chemokine receptor 3 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19762220 |
RGD:4145622 |
NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
|
|
G |
CCR5 |
C-C motif chemokine receptor 5 |
|
ISO |
Idiopathic Pneumonia Syndrome; mRNA:increased expression:lung (mouse) |
RGD |
PMID:15546955 |
RGD:4892103 |
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
|
|
G |
CCR6 |
C-C motif chemokine receptor 6 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 6:167,111,795...167,139,141
Ensembl chr 6:167,111,807...167,139,141
|
|
G |
CCR7 |
C-C motif chemokine receptor 7 |
|
IEP |
mRNA, protein:increased expression:lung |
RGD |
PMID:16394278 |
RGD:5130919 |
NCBI chr17:40,553,769...40,565,472
Ensembl chr17:40,551,081...40,565,472
|
|
G |
CCR9 |
C-C motif chemokine receptor 9 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 3:45,886,064...45,903,174
Ensembl chr 3:45,884,425...45,903,174
|
|
G |
CD14 |
CD14 molecule |
|
IEP |
protein:increased expression:multiple |
RGD |
PMID:20302606 |
RGD:4144794 |
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
|
|
G |
CD163 |
CD163 molecule |
|
IEP |
associated with liver disease;protein:increased expression:blood serum (human) |
RGD |
PMID:26339412 |
RGD:11251207 |
NCBI chr12:7,470,811...7,503,777
Ensembl chr12:7,470,811...7,503,893
|
|
G |
CD40LG |
CD40 ligand |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr X:136,648,158...136,660,390
Ensembl chr X:136,648,158...136,660,390
|
|
G |
COQ6 |
coenzyme Q6, monooxygenase |
|
IAGP |
ClinVar Annotator: match by term: increased susceptibility to pneumonia |
ClinVar |
|
|
NCBI chr14:73,949,918...73,963,670
Ensembl chr14:73,949,926...73,963,670
|
|
G |
CRHR2 |
corticotropin releasing hormone receptor 2 |
|
ISO |
|
RGD |
PMID:16855006 |
RGD:5130933 |
NCBI chr 7:30,651,942...30,700,103
Ensembl chr 7:30,651,942...30,700,129
|
|
G |
CRP |
C-reactive protein |
disease_progression severity |
IEP |
|
RGD |
PMID:21439658 PMID:21258955 |
RGD:5131291, RGD:5131283 |
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
|
|
G |
CSF2 |
colony stimulating factor 2 |
|
ISO EXP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11732872 PMID:19633061 |
RGD:4142837 |
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
CSF3R |
colony stimulating factor 3 receptor |
|
HEP |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 1:36,466,043...36,483,314
Ensembl chr 1:36,466,043...36,483,278
|
|
G |
CSK |
C-terminal Src kinase |
|
ISO |
|
RGD |
PMID:14975240 |
RGD:5134363 |
NCBI chr15:74,782,080...74,803,197
Ensembl chr15:74,782,080...74,803,197
|
|
G |
CX3CL1 |
C-X3-C motif chemokine ligand 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr16:57,372,490...57,385,044
Ensembl chr16:57,372,477...57,385,044
|
| |